<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Nick Brazeau</title>
    <link>https://nicholasbrazeau.com/</link>
      <atom:link href="https://nicholasbrazeau.com/index.xml" rel="self" type="application/rss+xml" />
    <description>Nick Brazeau</description>
    <generator>Source Themes Academic (https://sourcethemes.com/academic/)</generator><language>en-us</language><copyright>© 2025 Nicholas Brazeau</copyright><lastBuildDate>Wed, 13 Nov 2024 00:00:00 +0000</lastBuildDate>
    <image>
      <url>https://nicholasbrazeau.com/img/headers/tree.jpg</url>
      <title>Nick Brazeau</title>
      <link>https://nicholasbrazeau.com/</link>
    </image>
    
    <item>
      <title>Identity by Descent: Tracing Malaria&#39;s Family Tree</title>
      <link>https://nicholasbrazeau.com/2024/11/13/identity-by-descent-tracing-malarias-family-tree/</link>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2024/11/13/identity-by-descent-tracing-malarias-family-tree/</guid>
      <description>&lt;h2 id=&#34;the-genetic-fingerprint-of-transmission&#34;&gt;The Genetic Fingerprint of Transmission&lt;/h2&gt;
&lt;p&gt;Every time a malaria parasite reproduces, it creates an opportunity to trace ancestry. When two parasites share large segments of identical DNA, it&amp;rsquo;s not coincidence—it&amp;rsquo;s evidence of recent common inheritance. This is &lt;strong&gt;Identity by Descent (IBD)&lt;/strong&gt;, and it&amp;rsquo;s revolutionizing how we understand malaria transmission.&lt;/p&gt;
&lt;p&gt;Unlike traditional surveillance that tracks where people get infected, IBD tracks where &lt;em&gt;parasites&lt;/em&gt; came from. This molecular genealogy reveals:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Transmission chains&lt;/strong&gt; — Which infections are connected?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Imported vs. local cases&lt;/strong&gt; — Is this a new introduction or local transmission?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Connectivity patterns&lt;/strong&gt; — Which villages/regions exchange parasites?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Elimination progress&lt;/strong&gt; — Are we interrupting transmission or just suppressing it?&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Let&amp;rsquo;s explore how IBD works and why it matters for malaria control.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;identity-by-state-vs-identity-by-descent&#34;&gt;Identity by State vs. Identity by Descent&lt;/h2&gt;
&lt;p&gt;Before diving into IBD, we need to understand a critical distinction:&lt;/p&gt;
&lt;h3 id=&#34;identity-by-state-ibs&#34;&gt;Identity by State (IBS)&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;IBS&lt;/strong&gt; simply means &amp;ldquo;the alleles are the same.&amp;rdquo; Two parasites have IBS at a locus if they both have allele &amp;ldquo;A&amp;rdquo; at that position.&lt;/p&gt;
&lt;p&gt;IBS can occur through multiple mechanisms:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Common ancestry&lt;/strong&gt; (they inherited &amp;ldquo;A&amp;rdquo; from a shared ancestor)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Convergent evolution&lt;/strong&gt; (both independently mutated to &amp;ldquo;A&amp;rdquo;)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Random chance&lt;/strong&gt; (allele &amp;ldquo;A&amp;rdquo; is common in the population)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Selection&lt;/strong&gt; (allele &amp;ldquo;A&amp;rdquo; provides fitness advantage)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;IBS is easy to measure but hard to interpret. Just because two parasites share an allele doesn&amp;rsquo;t mean they&amp;rsquo;re closely related.&lt;/p&gt;
&lt;h3 id=&#34;identity-by-descent-ibd&#34;&gt;Identity by Descent (IBD)&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;IBD&lt;/strong&gt; means &amp;ldquo;the DNA was inherited from a recent common ancestor.&amp;rdquo; Two parasites have IBD if they both inherited the &lt;em&gt;same copy&lt;/em&gt; of DNA from a shared ancestor—not just the same allele sequence, but the actual identical genetic material.&lt;/p&gt;
&lt;p&gt;IBD is difficult to measure (requires statistical models) but easy to interpret: &lt;strong&gt;High IBD = recent shared ancestry.&lt;/strong&gt;&lt;/p&gt;
&lt;h3 id=&#34;the-key-difference&#34;&gt;The Key Difference&lt;/h3&gt;
&lt;p&gt;Imagine two people both have blue eyes (IBS). This could mean:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;They&amp;rsquo;re siblings (IBD—inherited from same parents)&lt;/li&gt;
&lt;li&gt;They&amp;rsquo;re unrelated but blue eyes are common in their population (IBS, not IBD)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;IBD methods use patterns across the genome to distinguish these scenarios.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;why-ibd-matters-more-than-ibs&#34;&gt;Why IBD Matters More Than IBS&lt;/h2&gt;
&lt;p&gt;Consider a simple example with two malaria parasites:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Scenario 1: High IBS, Low IBD&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;80% of alleles match&lt;/li&gt;
&lt;li&gt;Matches are scattered randomly across the genome&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt; The parasites are from the same geographic region but not closely related&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Scenario 2: High IBS, High IBD&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;80% of alleles match&lt;/li&gt;
&lt;li&gt;Matches occur in &lt;em&gt;long continuous blocks&lt;/em&gt; across chromosomes&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt; The parasites shared a recent common ancestor (within a few transmission cycles)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The pattern matters more than the raw percentage. &lt;strong&gt;IBD looks for contiguous blocks of shared alleles&lt;/strong&gt;, not just overall similarity.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-biology-behind-ibd&#34;&gt;The Biology Behind IBD&lt;/h2&gt;
&lt;p&gt;IBD works because of &lt;strong&gt;recombination&lt;/strong&gt;—the shuffling of genetic material during sexual reproduction in the mosquito.&lt;/p&gt;
&lt;h3 id=&#34;recombination-breaks-down-ibd&#34;&gt;Recombination Breaks Down IBD&lt;/h3&gt;
&lt;p&gt;When malaria parasites mate in a mosquito:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Two parent parasites exchange DNA through recombination&lt;/li&gt;
&lt;li&gt;This creates offspring with mosaic genomes—some segments from parent 1, some from parent 2&lt;/li&gt;
&lt;li&gt;Over generations, recombination &lt;strong&gt;breaks up IBD segments&lt;/strong&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;The key insight: &lt;strong&gt;Recombination is clock-like&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Recent ancestry&lt;/strong&gt; → Large IBD segments (few recombination events)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Distant ancestry&lt;/strong&gt; → Small/no IBD segments (many recombination events)&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;the-time-scale&#34;&gt;The Time Scale&lt;/h3&gt;
&lt;p&gt;IBD is exquisitely sensitive to recent transmission:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;1-2 transmission cycles ago&lt;/strong&gt;: IBD segments span megabases (millions of basepairs)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;5-10 transmission cycles&lt;/strong&gt;: IBD segments shrink to kilobases&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;&amp;gt;20 transmission cycles&lt;/strong&gt;: IBD segments are too small to reliably detect&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This makes IBD perfect for tracking transmission over weeks to months—exactly the timescale relevant for outbreak response.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;measuring-ibd-the-hmm-approach&#34;&gt;Measuring IBD: The HMM Approach&lt;/h2&gt;
&lt;p&gt;The gold standard method for detecting IBD in malaria is &lt;strong&gt;hmmIBD&lt;/strong&gt; (Hidden Markov Model for IBD), developed by Bob Verity and colleagues.&lt;/p&gt;
&lt;h3 id=&#34;the-hidden-markov-model-framework&#34;&gt;The Hidden Markov Model Framework&lt;/h3&gt;
&lt;p&gt;hmmIBD treats the genome as a sequence of positions that are either:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;IBD&lt;/strong&gt; (inherited from common ancestor)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Not IBD&lt;/strong&gt; (independent inheritance)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The &amp;ldquo;hidden&amp;rdquo; part: You can&amp;rsquo;t directly observe IBD status. You only observe whether alleles match (IBS).&lt;/p&gt;
&lt;p&gt;The model asks: &lt;strong&gt;Given the observed pattern of matching/non-matching alleles, what&amp;rsquo;s the most likely sequence of IBD/non-IBD states along the chromosome?&lt;/strong&gt;&lt;/p&gt;
&lt;h3 id=&#34;key-inputs&#34;&gt;Key Inputs&lt;/h3&gt;
&lt;p&gt;hmmIBD requires:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;Genetic data&lt;/strong&gt; — SNP genotypes for parasite pairs&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Population allele frequencies&lt;/strong&gt; — How common is each allele?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Recombination rate&lt;/strong&gt; — How fast does recombination break up IBD?&lt;/li&gt;
&lt;/ol&gt;
&lt;h3 id=&#34;the-logic&#34;&gt;The Logic&lt;/h3&gt;
&lt;p&gt;At each position, the model calculates:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;If IBD at this position:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Matching alleles are very likely (inherited same segment)&lt;/li&gt;
&lt;li&gt;Non-matching alleles are rare (only if rare mutation occurred)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;If not IBD at this position:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Matching alleles depend on population frequency (could match by chance)&lt;/li&gt;
&lt;li&gt;Non-matching alleles are common&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;By comparing these probabilities across the genome, hmmIBD identifies long stretches that are more likely IBD than expected by chance.&lt;/p&gt;
&lt;h3 id=&#34;output-ibd-fraction&#34;&gt;Output: IBD Fraction&lt;/h3&gt;
&lt;p&gt;hmmIBD reports an &lt;strong&gt;IBD fraction&lt;/strong&gt; for each parasite pair:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;IBD = 0&lt;/strong&gt;: No shared ancestry detected&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;IBD = 0.5&lt;/strong&gt;: Half the genome is IBD (sibling parasites or parent-offspring)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;IBD = 1.0&lt;/strong&gt;: Entire genome is IBD (clones or nearly identical strains)&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;ibd-in-action-use-cases&#34;&gt;IBD in Action: Use Cases&lt;/h2&gt;
&lt;h3 id=&#34;1-reconstructing-transmission-chains&#34;&gt;1. Reconstructing Transmission Chains&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;The Problem:&lt;/strong&gt; During an outbreak, public health teams need to know: Who infected whom?&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The IBD Solution:&lt;/strong&gt; High IBD (&amp;gt;0.8) between parasites from two people indicates direct transmission or transmission through a common intermediate within 1-2 cycles.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Real Example:&lt;/strong&gt; In a village outbreak in Eswatini:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Person A infected Week 1&lt;/li&gt;
&lt;li&gt;Person B infected Week 3&lt;/li&gt;
&lt;li&gt;IBD(A,B) = 0.92&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt; Person B was likely infected directly from Person A or from someone A infected. This identified the transmission chain and guided contact tracing.&lt;/p&gt;
&lt;h3 id=&#34;2-detecting-imported-cases&#34;&gt;2. Detecting Imported Cases&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;The Problem:&lt;/strong&gt; Is malaria resurgence due to local transmission or importation?&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The IBD Solution:&lt;/strong&gt; Compare new infections to circulating local strains:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;High IBD with local strains&lt;/strong&gt; → Local transmission&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Low IBD with local strains&lt;/strong&gt; → Importation&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Real Example:&lt;/strong&gt; Zanzibar elimination program:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Most new cases had IBD &amp;lt; 0.1 with existing cases&lt;/li&gt;
&lt;li&gt;High IBD with parasites from Tanzania mainland (150 km away)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Conclusion:&lt;/strong&gt; 80% of cases were imported, not local transmission&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Action:&lt;/strong&gt; Shifted focus to border screening rather than local vector control&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;3-measuring-connectivity-between-regions&#34;&gt;3. Measuring Connectivity Between Regions&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;The Problem:&lt;/strong&gt; Do two villages exchange parasites? At what rate?&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The IBD Solution:&lt;/strong&gt; High mean IBD between villages indicates frequent parasite flow.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Real Example:&lt;/strong&gt; DRC spatial analysis:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Village pairs &amp;lt;50 km apart: Mean IBD = 0.35&lt;/li&gt;
&lt;li&gt;Village pairs &amp;gt;200 km apart: Mean IBD = 0.05&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt; Most transmission is local (&amp;lt;50 km), but long-distance importation does occur&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Action:&lt;/strong&gt; Targeted interventions in high-connectivity clusters&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;4-elimination-monitoring&#34;&gt;4. Elimination Monitoring&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;The Problem:&lt;/strong&gt; Are we interrupting transmission or just reducing cases?&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;The IBD Solution:&lt;/strong&gt; Track IBD over time:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Rising IBD&lt;/strong&gt; → Transmission becoming more clonal (fewer sources)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Falling IBD&lt;/strong&gt; → Transmission remains diverse (many sources)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Real Example:&lt;/strong&gt; Zambia MDA campaign:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Pre-intervention: Mean IBD = 0.15 (diverse transmission)&lt;/li&gt;
&lt;li&gt;Post-intervention: Mean IBD = 0.45 (clonal outbreaks from few remaining sources)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt; Successfully interrupted most transmission, but pockets remain&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Action:&lt;/strong&gt; Targeted mop-up in high-IBD clusters&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;ibd-vs-other-relatedness-measures&#34;&gt;IBD vs. Other Relatedness Measures&lt;/h2&gt;
&lt;p&gt;How does IBD compare to alternatives?&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th&gt;Method&lt;/th&gt;
&lt;th&gt;What it Measures&lt;/th&gt;
&lt;th&gt;Time Scale&lt;/th&gt;
&lt;th&gt;Best For&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;IBD&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Shared ancestry via recombination&lt;/td&gt;
&lt;td&gt;1-20 generations&lt;/td&gt;
&lt;td&gt;Transmission chains, importation&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;F_ST&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Population differentiation&lt;/td&gt;
&lt;td&gt;100s-1000s generations&lt;/td&gt;
&lt;td&gt;Geographic structure&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;PCA&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Genetic similarity&lt;/td&gt;
&lt;td&gt;Varies&lt;/td&gt;
&lt;td&gt;Population structure visualization&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;TMRCA&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Time to common ancestor&lt;/td&gt;
&lt;td&gt;Variable&lt;/td&gt;
&lt;td&gt;Evolutionary timescales&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Phylogeny&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Evolutionary relationships&lt;/td&gt;
&lt;td&gt;100s-1000s generations&lt;/td&gt;
&lt;td&gt;Strain origins, drug resistance&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;&lt;strong&gt;IBD&amp;rsquo;s sweet spot:&lt;/strong&gt; Detecting relationships over weeks to months—the timescale of malaria control operations.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;technical-challenges&#34;&gt;Technical Challenges&lt;/h2&gt;
&lt;h3 id=&#34;challenge-1-complexity-of-infection-coi&#34;&gt;Challenge 1: Complexity of Infection (COI)&lt;/h3&gt;
&lt;p&gt;Most infections are polyclonal (multiple parasite strains). This creates ambiguity:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Which clone from person A matches which clone from person B?&lt;/li&gt;
&lt;li&gt;Is high IBD due to relatedness or just the same dominant clone?&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Solution:&lt;/strong&gt; Methods like &lt;code&gt;hmmIBD-MCMC&lt;/code&gt; probabilistically handle polyclonal infections by integrating over possible clone pairings.&lt;/p&gt;
&lt;h3 id=&#34;challenge-2-population-allele-frequencies&#34;&gt;Challenge 2: Population Allele Frequencies&lt;/h3&gt;
&lt;p&gt;IBD estimation requires accurate population allele frequencies. Using frequencies from the wrong population biases IBD estimates.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Solution:&lt;/strong&gt; Estimate frequencies from the same samples you&amp;rsquo;re analyzing, or use population-specific reference panels.&lt;/p&gt;
&lt;h3 id=&#34;challenge-3-low-density-snp-panels&#34;&gt;Challenge 3: Low-Density SNP Panels&lt;/h3&gt;
&lt;p&gt;IBD works best with whole-genome sequencing. But cost-effective panels use 50-200 SNPs—too sparse for traditional IBD.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Solution:&lt;/strong&gt; New methods like &lt;code&gt;dEploid&lt;/code&gt; and &lt;code&gt;Coil&lt;/code&gt; use probabilistic models to estimate IBD from sparse data by leveraging linkage information.&lt;/p&gt;
&lt;h3 id=&#34;challenge-4-recombination-rate-uncertainty&#34;&gt;Challenge 4: Recombination Rate Uncertainty&lt;/h3&gt;
&lt;p&gt;IBD estimation requires knowing the recombination rate. But malaria recombination rates vary by region and are imprecisely measured.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Solution:&lt;/strong&gt; Sensitivity analyses across plausible recombination rates to ensure results are robust.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-ibd-distance-relationship&#34;&gt;The IBD-Distance Relationship&lt;/h2&gt;
&lt;p&gt;One of the most consistent findings in malaria genomics: &lt;strong&gt;IBD decays exponentially with geographic distance.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;The relationship follows:&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;IBD(d) = IBD_0 × exp(-d / L)
&lt;/code&gt;&lt;/pre&gt;&lt;p&gt;Where:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;code&gt;d&lt;/code&gt; = geographic distance between samples&lt;/li&gt;
&lt;li&gt;&lt;code&gt;L&lt;/code&gt; = characteristic dispersal distance (typically 20-80 km)&lt;/li&gt;
&lt;li&gt;&lt;code&gt;IBD_0&lt;/code&gt; = baseline IBD at distance zero&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This relationship has profound implications:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Short dispersal distance (L = 20 km):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Transmission is highly localized&lt;/li&gt;
&lt;li&gt;Interventions can focus on small areas&lt;/li&gt;
&lt;li&gt;Elimination is feasible region-by-region&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Long dispersal distance (L = 80 km):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Parasites travel far (human migration, mosquito movement)&lt;/li&gt;
&lt;li&gt;Interventions must cover large areas&lt;/li&gt;
&lt;li&gt;Elimination requires coordinated regional efforts&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;real-world-variation&#34;&gt;Real-World Variation&lt;/h3&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th&gt;Region&lt;/th&gt;
&lt;th&gt;Dispersal Distance (L)&lt;/th&gt;
&lt;th&gt;Interpretation&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;Rural DRC&lt;/td&gt;
&lt;td&gt;15-25 km&lt;/td&gt;
&lt;td&gt;Hyper-local transmission&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Zanzibar&lt;/td&gt;
&lt;td&gt;40-60 km&lt;/td&gt;
&lt;td&gt;Moderate dispersal&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Southeast Asia&lt;/td&gt;
&lt;td&gt;80-150 km&lt;/td&gt;
&lt;td&gt;High mobility (border crossings)&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;hr&gt;
&lt;h2 id=&#34;ibd-network-analysis&#34;&gt;IBD Network Analysis&lt;/h2&gt;
&lt;p&gt;Modern IBD analysis treats relatedness as a &lt;strong&gt;network&lt;/strong&gt;:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Nodes&lt;/strong&gt; = individual infections&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Edges&lt;/strong&gt; = high IBD connections (&amp;gt;0.5)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Network metrics reveal transmission structure:&lt;/p&gt;
&lt;h3 id=&#34;clustering-coefficient&#34;&gt;Clustering Coefficient&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;High clustering&lt;/strong&gt; → Tight transmission networks (local outbreaks)
&lt;strong&gt;Low clustering&lt;/strong&gt; → Diffuse transmission (importation-driven)&lt;/p&gt;
&lt;h3 id=&#34;community-detection&#34;&gt;Community Detection&lt;/h3&gt;
&lt;p&gt;Algorithms like Louvain method identify &lt;strong&gt;transmission clusters&lt;/strong&gt;—groups of highly connected infections.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Use case:&lt;/strong&gt; In a multi-village outbreak, community detection identified three independent transmission clusters. Targeted interventions in these clusters interrupted transmission faster than blanket approaches.&lt;/p&gt;
&lt;h3 id=&#34;network-centrality&#34;&gt;Network Centrality&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;High-centrality nodes&lt;/strong&gt; = infections connected to many others
&lt;strong&gt;Interpretation:&lt;/strong&gt; Potential superspreaders or hubs in transmission network&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-future-real-time-ibd-surveillance&#34;&gt;The Future: Real-Time IBD Surveillance&lt;/h2&gt;
&lt;p&gt;Current research is pushing toward &lt;strong&gt;operational IBD surveillance&lt;/strong&gt;:&lt;/p&gt;
&lt;h3 id=&#34;portable-sequencing&#34;&gt;Portable Sequencing&lt;/h3&gt;
&lt;p&gt;Oxford Nanopore MinION enables:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Field-deployable sequencing&lt;/li&gt;
&lt;li&gt;Results within 24 hours&lt;/li&gt;
&lt;li&gt;Immediate IBD-based outbreak response&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;automated-pipelines&#34;&gt;Automated Pipelines&lt;/h3&gt;
&lt;p&gt;Software like &lt;code&gt;IBD-pipeline&lt;/code&gt; and &lt;code&gt;malariaibdR&lt;/code&gt; automate:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;VCF processing&lt;/li&gt;
&lt;li&gt;IBD calculation&lt;/li&gt;
&lt;li&gt;Network visualization&lt;/li&gt;
&lt;li&gt;Report generation&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;integration-with-case-data&#34;&gt;Integration with Case Data&lt;/h3&gt;
&lt;p&gt;Linking IBD networks with:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Case GPS coordinates&lt;/li&gt;
&lt;li&gt;Travel history&lt;/li&gt;
&lt;li&gt;Intervention coverage&lt;/li&gt;
&lt;li&gt;Environmental data&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Vision:&lt;/strong&gt; Real-time transmission network dashboards guiding intervention deployment.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;what-weve-learned&#34;&gt;What We&amp;rsquo;ve Learned&lt;/h2&gt;
&lt;p&gt;From a decade of IBD research in malaria, key insights have emerged:&lt;/p&gt;
&lt;h3 id=&#34;1-most-transmission-is-local&#34;&gt;1. Most Transmission is Local&lt;/h3&gt;
&lt;p&gt;IBD consistently shows:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;60-80% of transmission occurs &amp;lt;10 km from source&lt;/li&gt;
&lt;li&gt;Super-spreaders are rare&lt;/li&gt;
&lt;li&gt;Transmission chains are short (2-4 hops)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Implication:&lt;/strong&gt; Reactive case detection within 500m-1km of index cases is effective.&lt;/p&gt;
&lt;h3 id=&#34;2-importation-drives-resurgence&#34;&gt;2. Importation Drives Resurgence&lt;/h3&gt;
&lt;p&gt;In pre-elimination settings:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;50-90% of new cases show low IBD with local strains&lt;/li&gt;
&lt;li&gt;Importation overwhelms local transmission&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Implication:&lt;/strong&gt; Border screening and treatment of travelers is critical for elimination.&lt;/p&gt;
&lt;h3 id=&#34;3-ibd-tracks-interventions&#34;&gt;3. IBD Tracks Interventions&lt;/h3&gt;
&lt;p&gt;IBD responds faster than case counts to interventions:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Mass drug administration: IBD increases within weeks&lt;/li&gt;
&lt;li&gt;Indoor residual spraying: IBD decreases over months&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Implication:&lt;/strong&gt; IBD provides early feedback on intervention effectiveness.&lt;/p&gt;
&lt;h3 id=&#34;4-elimination-requires-regional-coordination&#34;&gt;4. Elimination Requires Regional Coordination&lt;/h3&gt;
&lt;p&gt;High IBD across regions demonstrates:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Parasites don&amp;rsquo;t respect administrative boundaries&lt;/li&gt;
&lt;li&gt;Isolated elimination efforts are vulnerable to reimportation&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Implication:&lt;/strong&gt; Coordination at &amp;gt;100 km scales is essential.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-bottom-line&#34;&gt;The Bottom Line&lt;/h2&gt;
&lt;p&gt;Identity by descent transforms malaria genomic data from a population-level snapshot into a transmission-level movie. By tracing shared ancestry, IBD reveals:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Who infected whom&lt;/li&gt;
&lt;li&gt;Where parasites came from&lt;/li&gt;
&lt;li&gt;Which villages are connected&lt;/li&gt;
&lt;li&gt;Whether elimination is progressing&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;As sequencing costs decline and field-deployable platforms mature, IBD surveillance is transitioning from research tool to operational capability.&lt;/p&gt;
&lt;p&gt;The future of malaria elimination won&amp;rsquo;t just count cases—it will map transmission networks in real-time and target interventions at the precise locations where transmission persists.&lt;/p&gt;
&lt;p&gt;IBD gives us the resolution to see transmission at its finest scale: the links between individual infections. And in those links lie the keys to elimination.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;further-reading&#34;&gt;Further Reading&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Key Papers:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Verity R, et al. (2020). &amp;ldquo;The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC.&amp;rdquo; &lt;em&gt;Nature Communications&lt;/em&gt;.&lt;/li&gt;
&lt;li&gt;Taylor AR, et al. (2019). &amp;ldquo;Quantifying connectivity between local Plasmodium falciparum malaria parasite populations using identity by descent.&amp;rdquo; &lt;em&gt;PLoS Genetics&lt;/em&gt;.&lt;/li&gt;
&lt;li&gt;Schaffner SF, et al. (2018). &amp;ldquo;hmmIBD: software to infer pairwise identity by descent between haploid genotypes.&amp;rdquo; &lt;em&gt;Malaria Journal&lt;/em&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Software:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/glipsnort/hmmIBD&#34;&gt;hmmIBD&lt;/a&gt; - Hidden Markov Model for IBD detection&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/bahlolab/isoRelate&#34;&gt;isoRelate&lt;/a&gt; - IBD-based relationship estimation&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/EPPIcenter/dcifer&#34;&gt;dcifer&lt;/a&gt; - Identity by descent from polyclonal infections&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/bailey-lab/malariaibdR&#34;&gt;malariaibdR&lt;/a&gt; - IBD analysis pipeline&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Workshops:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Applied Malaria Molecular Surveillance (AMMS) - Annual workshop covering IBD methods&lt;/li&gt;
&lt;li&gt;Materials available at: &lt;a href=&#34;https://www.eppicenter.org&#34;&gt;AMMS Practicals&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Post drafted with assistance from Claude.AI&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>The Complexities of Complexity of Infection: Understanding Multiple Malaria Strains</title>
      <link>https://nicholasbrazeau.com/2024/11/13/the-complexities-of-complexity-of-infection-understanding-multiple-malaria-strains/</link>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2024/11/13/the-complexities-of-complexity-of-infection-understanding-multiple-malaria-strains/</guid>
      <description>&lt;h2 id=&#34;the-hidden-complexity-inside&#34;&gt;The Hidden Complexity Inside&lt;/h2&gt;
&lt;p&gt;When a mosquito infected with malaria bites a person, we typically think of it as transmitting &amp;ldquo;malaria.&amp;rdquo; But the reality is far more complex. That single mosquito bite might be transmitting one parasite strain—or five, or ten distinct genetic clones simultaneously.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Complexity of Infection (COI)&lt;/strong&gt; is the number of genetically distinct malaria parasite clones present in a single infection. Understanding COI is crucial for:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Transmission intensity assessment&lt;/strong&gt; — High COI indicates high transmission&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Drug resistance monitoring&lt;/strong&gt; — Polyclonal infections complicate resistance detection&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Vaccine evaluation&lt;/strong&gt; — Multiple strains can confound efficacy estimates&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Elimination strategies&lt;/strong&gt; — Low COI suggests transmission can be interrupted&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;But measuring COI is surprisingly challenging. Let&amp;rsquo;s explore how we do it and why it matters.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;monoclonal-vs-polyclonal-infections&#34;&gt;Monoclonal vs. Polyclonal Infections&lt;/h2&gt;
&lt;h3 id=&#34;monoclonal-infections-coi--1&#34;&gt;Monoclonal Infections (COI = 1)&lt;/h3&gt;
&lt;p&gt;A &lt;strong&gt;monoclonal&lt;/strong&gt; infection contains a single parasite clone. This occurs when:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Transmission intensity is low (few infectious mosquitoes)&lt;/li&gt;
&lt;li&gt;The infected person has limited exposure&lt;/li&gt;
&lt;li&gt;Previous infections have been cleared&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;From a genetic perspective, a monoclonal infection is &amp;ldquo;simple&amp;rdquo;—you&amp;rsquo;re sequencing DNA from one parasite genome. Any genetic variation you observe is sequencing error, not biological complexity.&lt;/p&gt;
&lt;h3 id=&#34;polyclonal-infections-coi--1&#34;&gt;Polyclonal Infections (COI &amp;gt; 1)&lt;/h3&gt;
&lt;p&gt;A &lt;strong&gt;polyclonal&lt;/strong&gt; infection contains multiple distinct clones. This happens through two mechanisms:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;1. Superinfection&lt;/strong&gt; — The person is bitten by multiple infected mosquitoes over time, each delivering different parasite clones. This is the dominant mechanism in high-transmission settings.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;2. Cotransmission&lt;/strong&gt; — A single mosquito carries and transmits multiple distinct clones simultaneously. This occurs when the mosquito previously fed on a person with a polyclonal infection.&lt;/p&gt;
&lt;p&gt;Polyclonal infections are the norm in high-transmission areas:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Sub-Saharan Africa&lt;/strong&gt;: Mean COI = 2-5 clones per infection&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Southeast Asia&lt;/strong&gt;: Mean COI = 1-2 clones per infection&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Low transmission areas&lt;/strong&gt;: Mean COI ≈ 1 clone per infection&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-coi-transmission-relationship&#34;&gt;The COI-Transmission Relationship&lt;/h2&gt;
&lt;p&gt;COI is a powerful proxy for transmission intensity. Here&amp;rsquo;s why:&lt;/p&gt;
&lt;p&gt;In &lt;strong&gt;high-transmission settings&lt;/strong&gt; (many infected mosquitoes):&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;People are bitten frequently by infected mosquitoes&lt;/li&gt;
&lt;li&gt;Each bite can introduce new clones (superinfection)&lt;/li&gt;
&lt;li&gt;COI accumulates over time → polyclonal infections are common&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;In &lt;strong&gt;low-transmission settings&lt;/strong&gt; (few infected mosquitoes):&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;People are rarely bitten by infected mosquitoes&lt;/li&gt;
&lt;li&gt;Infections are typically from a single mosquito bite&lt;/li&gt;
&lt;li&gt;COI remains low → monoclonal infections dominate&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This relationship is so strong that epidemiologists use COI as a &lt;strong&gt;molecular marker of transmission intensity&lt;/strong&gt;—even in the absence of direct entomological data (mosquito counts, biting rates, etc.).&lt;/p&gt;
&lt;h3 id=&#34;real-world-example-drc-malaria-study&#34;&gt;Real-World Example: DRC Malaria Study&lt;/h3&gt;
&lt;p&gt;In our nationwide study of malaria in the Democratic Republic of the Congo, we found dramatic geographic variation in COI:&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th&gt;Region&lt;/th&gt;
&lt;th&gt;Transmission Intensity&lt;/th&gt;
&lt;th&gt;Mean COI&lt;/th&gt;
&lt;th&gt;% Polyclonal&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;Kinshasa (urban, low)&lt;/td&gt;
&lt;td&gt;Low&lt;/td&gt;
&lt;td&gt;1.2&lt;/td&gt;
&lt;td&gt;18%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Eastern highlands&lt;/td&gt;
&lt;td&gt;Moderate&lt;/td&gt;
&lt;td&gt;2.1&lt;/td&gt;
&lt;td&gt;65%&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Western rainforest&lt;/td&gt;
&lt;td&gt;High&lt;/td&gt;
&lt;td&gt;3.8&lt;/td&gt;
&lt;td&gt;94%&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;The gradient is striking: In low-transmission Kinshasa, most infections are monoclonal. In high-transmission rainforest regions, nearly everyone has multiple parasite clones.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;measuring-coi-the-challenge&#34;&gt;Measuring COI: The Challenge&lt;/h2&gt;
&lt;p&gt;Here&amp;rsquo;s the problem: You can&amp;rsquo;t just &amp;ldquo;count&amp;rdquo; parasite clones under a microscope. Genetically distinct clones look identical morphologically. You need &lt;strong&gt;molecular methods&lt;/strong&gt; to distinguish them.&lt;/p&gt;
&lt;p&gt;The key insight: &lt;strong&gt;Polyclonal infections contain mixtures of parasite DNA.&lt;/strong&gt; When you sequence a blood sample with COI = 3, you&amp;rsquo;re sequencing DNA from three distinct parasite genomes simultaneously. The challenge is disentangling that mixture.&lt;/p&gt;
&lt;h3 id=&#34;the-heterozygosity-signal&#34;&gt;The Heterozygosity Signal&lt;/h3&gt;
&lt;p&gt;The primary signal of polyclonal infection is &lt;strong&gt;within-host heterozygosity&lt;/strong&gt;—the presence of multiple alleles at a single genetic locus within one host.&lt;/p&gt;
&lt;p&gt;Consider a single SNP (single nucleotide polymorphism) in the parasite genome:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Monoclonal infection (COI = 1):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;The parasite has either allele A or allele T&lt;/li&gt;
&lt;li&gt;The host sample shows: 100% A or 100% T&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;No within-host heterozygosity&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Polyclonal infection (COI = 3):&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Clone 1 has allele A&lt;/li&gt;
&lt;li&gt;Clone 2 has allele A&lt;/li&gt;
&lt;li&gt;Clone 3 has allele T&lt;/li&gt;
&lt;li&gt;The host sample shows: 67% A, 33% T&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Within-host heterozygosity detected!&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;By counting how many SNPs show within-host heterozygosity across the genome, we can estimate COI.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;method-1-the-real-mccoil&#34;&gt;Method 1: THE REAL McCOIL&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;THE REAL McCOIL&lt;/strong&gt; (The Real McCoy method for Complexity Of Infection in Loci) is the most widely used COI estimation method. Developed by the EPPIcenter research group, it uses a probabilistic framework to estimate COI from SNP data.&lt;/p&gt;
&lt;h3 id=&#34;the-coin-flip-analogy&#34;&gt;The Coin Flip Analogy&lt;/h3&gt;
&lt;p&gt;Think of each parasite clone as a coin flip:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Clone contributes allele A → Heads&lt;/li&gt;
&lt;li&gt;Clone contributes allele T → Tails&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;For a SNP to be heterozygous&lt;/strong&gt;, you need:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;At least one &amp;ldquo;heads&amp;rdquo; (allele A)&lt;/li&gt;
&lt;li&gt;At least one &amp;ldquo;tails&amp;rdquo; (allele T)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The probability of this happening depends on:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;COI&lt;/strong&gt; — More clones = more coin flips = higher chance of seeing both alleles&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Population allele frequency&lt;/strong&gt; — If allele A is rare (10% frequency), seeing it requires more &amp;ldquo;flips&amp;rdquo;&lt;/li&gt;
&lt;/ol&gt;
&lt;h3 id=&#34;the-mccoil-model&#34;&gt;The McCOIL Model&lt;/h3&gt;
&lt;p&gt;McCOIL uses a likelihood framework:&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;P(heterozygous | COI, p) = 1 - p^COI - (1-p)^COI
&lt;/code&gt;&lt;/pre&gt;&lt;p&gt;Where:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;code&gt;COI&lt;/code&gt; is the complexity of infection (what we&amp;rsquo;re estimating)&lt;/li&gt;
&lt;li&gt;&lt;code&gt;p&lt;/code&gt; is the population-level allele frequency&lt;/li&gt;
&lt;li&gt;The equation says: &amp;ldquo;Probability of heterozygous = 1 minus (all clones have A) minus (all clones have T)&amp;rdquo;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;By observing heterozygous sites across many SNPs and knowing population allele frequencies, McCOIL uses maximum likelihood to estimate COI.&lt;/p&gt;
&lt;h3 id=&#34;why-it-works&#34;&gt;Why It Works&lt;/h3&gt;
&lt;p&gt;The key insight: &lt;strong&gt;The number of heterozygous sites increases with COI, but saturates.&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;COI = 1: 0 heterozygous sites (impossible to have both alleles with one clone)&lt;/li&gt;
&lt;li&gt;COI = 2: ~20-30% of SNPs heterozygous (depends on allele frequencies)&lt;/li&gt;
&lt;li&gt;COI = 5: ~40-50% of SNPs heterozygous&lt;/li&gt;
&lt;li&gt;COI = 10: ~50-60% of SNPs heterozygous (saturation)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;McCOIL leverages this relationship to back-calculate COI from the observed heterozygosity pattern.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;method-2-f_ws-within-host-diversity&#34;&gt;Method 2: F_WS (Within-Host Diversity)&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;F_WS&lt;/strong&gt; is an alternative approach that measures within-host diversity relative to population diversity.&lt;/p&gt;
&lt;h3 id=&#34;the-f-statistic-framework&#34;&gt;The F-Statistic Framework&lt;/h3&gt;
&lt;p&gt;F_WS is inspired by Wright&amp;rsquo;s F-statistics from population genetics:&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;F_WS = 1 - (H_W / H_S)
&lt;/code&gt;&lt;/pre&gt;&lt;p&gt;Where:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;code&gt;H_W&lt;/code&gt; = within-host heterozygosity (average across SNPs in one sample)&lt;/li&gt;
&lt;li&gt;&lt;code&gt;H_S&lt;/code&gt; = population heterozygosity (expected diversity in the population)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Interpretation:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;F_WS = 1&lt;/strong&gt;: Monoclonal infection (no within-host diversity)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;F_WS = 0&lt;/strong&gt;: Polyclonal infection with diversity matching the population&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;F_WS &amp;lt; 0&lt;/strong&gt;: Polyclonal infection with higher diversity than the population (cotransmission of divergent clones)&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;why-f_ws-is-useful&#34;&gt;Why F_WS is Useful&lt;/h3&gt;
&lt;p&gt;Unlike COI (a discrete count), F_WS is continuous. This makes it:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;More stable with sparse data&lt;/li&gt;
&lt;li&gt;Better for detecting subtle changes in transmission&lt;/li&gt;
&lt;li&gt;Easier to model statistically (no integer constraints)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;However, F_WS doesn&amp;rsquo;t give you an exact clone count—it&amp;rsquo;s a relative measure of genetic complexity.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;comparing-the-methods&#34;&gt;Comparing the Methods&lt;/h2&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th&gt;Feature&lt;/th&gt;
&lt;th&gt;THE REAL McCOIL&lt;/th&gt;
&lt;th&gt;F_WS&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Output&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Integer COI estimate&lt;/td&gt;
&lt;td&gt;Continuous diversity metric&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Interpretation&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Direct: &amp;ldquo;This person has 3 clones&amp;rdquo;&lt;/td&gt;
&lt;td&gt;Relative: &amp;ldquo;High within-host diversity&amp;rdquo;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Data requirements&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Moderate (50-100 SNPs)&lt;/td&gt;
&lt;td&gt;Flexible (works with fewer SNPs)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Sensitivity&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;High for COI 1-5, saturates above&lt;/td&gt;
&lt;td&gt;Linear across all ranges&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Computational cost&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;Moderate (likelihood optimization)&lt;/td&gt;
&lt;td&gt;Fast (simple calculation)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;&lt;strong&gt;Best use case&lt;/strong&gt;&lt;/td&gt;
&lt;td&gt;When you need exact clone counts&lt;/td&gt;
&lt;td&gt;When comparing populations or tracking trends&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;In practice, many researchers report &lt;strong&gt;both&lt;/strong&gt; metrics to provide complementary information.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;why-coi-matters-for-malaria-control&#34;&gt;Why COI Matters for Malaria Control&lt;/h2&gt;
&lt;h3 id=&#34;1-transmission-intensity-monitoring&#34;&gt;1. Transmission Intensity Monitoring&lt;/h3&gt;
&lt;p&gt;COI provides a &lt;strong&gt;molecular thermometer&lt;/strong&gt; for transmission:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Increasing COI → transmission is rising&lt;/li&gt;
&lt;li&gt;Decreasing COI → interventions are working&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This is especially valuable when traditional surveillance (case counts, mosquito abundance) is unreliable.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Example:&lt;/strong&gt; After mass drug administration in Zambia, researchers tracked COI decline from 2.8 to 1.4 over two years—direct molecular evidence that transmission was being interrupted.&lt;/p&gt;
&lt;h3 id=&#34;2-drug-resistance-surveillance&#34;&gt;2. Drug Resistance Surveillance&lt;/h3&gt;
&lt;p&gt;Detecting resistance mutations is straightforward in monoclonal infections—you either have the mutation or you don&amp;rsquo;t. But polyclonal infections create ambiguity:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Scenario:&lt;/strong&gt; A patient has COI = 4 with these clones:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Clone 1: Resistant (has mutation)&lt;/li&gt;
&lt;li&gt;Clone 2: Sensitive&lt;/li&gt;
&lt;li&gt;Clone 3: Sensitive&lt;/li&gt;
&lt;li&gt;Clone 4: Sensitive&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;When you sequence this sample, you might detect the resistance mutation at 25% frequency. Is this:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;A monoclonal infection with partial resistance?&lt;/li&gt;
&lt;li&gt;A polyclonal infection where most clones are sensitive?&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The answer determines treatment strategy. COI estimation helps disentangle these scenarios.&lt;/p&gt;
&lt;h3 id=&#34;3-vaccine-trial-interpretation&#34;&gt;3. Vaccine Trial Interpretation&lt;/h3&gt;
&lt;p&gt;In vaccine trials, polyclonal infections complicate efficacy estimates:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Did the vaccine fail, or did it prevent 2 out of 3 clones?&lt;/li&gt;
&lt;li&gt;Is a breakthrough infection after vaccination less complex than natural infection?&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Tracking COI before and after vaccination provides deeper insights into vaccine mechanisms.&lt;/p&gt;
&lt;h3 id=&#34;4-elimination-feasibility&#34;&gt;4. Elimination Feasibility&lt;/h3&gt;
&lt;p&gt;High COI indicates active, ongoing transmission—a major barrier to elimination. Before declaring an area ready for elimination efforts, COI surveillance ensures you&amp;rsquo;re not missing cryptic transmission.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;practical-considerations&#34;&gt;Practical Considerations&lt;/h2&gt;
&lt;h3 id=&#34;data-requirements&#34;&gt;Data Requirements&lt;/h3&gt;
&lt;p&gt;To estimate COI, you need:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Sequencing data&lt;/strong&gt; from blood samples (whole genome, amplicon, or targeted SNP panels)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Population allele frequencies&lt;/strong&gt; for the SNPs you&amp;rsquo;re analyzing&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Quality control&lt;/strong&gt; to distinguish real heterozygosity from sequencing error&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Most modern studies use:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;50-200 high-quality SNPs&lt;/li&gt;
&lt;li&gt;Minimum read depth: 20-30× coverage per SNP&lt;/li&gt;
&lt;li&gt;Population reference panels from the same geographic region&lt;/li&gt;
&lt;/ul&gt;
&lt;h3 id=&#34;technical-challenges&#34;&gt;Technical Challenges&lt;/h3&gt;
&lt;p&gt;&lt;strong&gt;Challenge 1: Sequencing Errors&lt;/strong&gt;
Low-frequency alleles might be errors, not real clones. Solution: Use stringent quality filters and higher coverage.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Challenge 2: Unequal Clone Proportions&lt;/strong&gt;
If one clone is 90% of the infection and another is 10%, the minority clone is hard to detect. Solution: Deep sequencing and probabilistic modeling.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Challenge 3: Population Allele Frequencies&lt;/strong&gt;
McCOIL requires accurate population frequencies. If you use wrong frequencies (e.g., from a different continent), COI estimates will be biased.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;what-weve-learned&#34;&gt;What We&amp;rsquo;ve Learned&lt;/h2&gt;
&lt;p&gt;From years of molecular surveillance, several patterns have emerged:&lt;/p&gt;
&lt;h3 id=&#34;coi-declines-with-age&#34;&gt;COI Declines with Age&lt;/h3&gt;
&lt;p&gt;In high-transmission areas:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Children: Mean COI = 3-4 (frequent exposure, accumulating clones)&lt;/li&gt;
&lt;li&gt;Adults: Mean COI = 2-3 (semi-immunity reduces superinfection)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This age gradient is a signature of acquired immunity shaping within-host parasite dynamics.&lt;/p&gt;
&lt;h3 id=&#34;coi-tracks-seasonality&#34;&gt;COI Tracks Seasonality&lt;/h3&gt;
&lt;p&gt;In seasonal transmission zones, COI fluctuates:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Dry season&lt;/strong&gt; (low transmission): COI drops to 1-2&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Wet season&lt;/strong&gt; (high transmission): COI rises to 3-5&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This provides real-time feedback on transmission dynamics without waiting for case count data.&lt;/p&gt;
&lt;h3 id=&#34;coi-differs-by-intervention&#34;&gt;COI Differs by Intervention&lt;/h3&gt;
&lt;p&gt;Mass drug administration drives COI down faster than insecticide-treated nets:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;MDA&lt;/strong&gt;: COI drops within months (clears existing infections)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;ITNs&lt;/strong&gt;: COI drops over years (reduces new infections gradually)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This difference helps optimize intervention strategies.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-future-beyond-simple-counts&#34;&gt;The Future: Beyond Simple Counts&lt;/h2&gt;
&lt;p&gt;Current research is pushing beyond simple COI estimates toward &lt;strong&gt;clone-level resolution&lt;/strong&gt;:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Haplotype-based methods&lt;/strong&gt; use linkage patterns across multiple SNPs to:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Identify individual clone haplotypes&lt;/li&gt;
&lt;li&gt;Reconstruct cotransmission networks&lt;/li&gt;
&lt;li&gt;Track specific strains across time and space&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Machine learning approaches&lt;/strong&gt; are being developed to:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Handle low-coverage sequencing data&lt;/li&gt;
&lt;li&gt;Estimate COI from partial genomes&lt;/li&gt;
&lt;li&gt;Integrate multiple data types (SNPs, microsatellites, copy number variants)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;These advances will transform COI from a summary statistic into a window on parasite population structure at the finest resolution.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-bottom-line&#34;&gt;The Bottom Line&lt;/h2&gt;
&lt;p&gt;Complexity of infection is a deceptively simple concept—just count the clones—that reveals profound insights into malaria transmission, drug resistance, and intervention effectiveness.&lt;/p&gt;
&lt;p&gt;By measuring within-host genetic diversity, we transform each infected person into a sentinel for transmission intensity. COI provides a molecular lens on epidemiology that complements traditional surveillance and enables precision public health.&lt;/p&gt;
&lt;p&gt;As malaria elimination efforts intensify, COI surveillance will be essential for:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Detecting cryptic transmission&lt;/li&gt;
&lt;li&gt;Monitoring intervention impact&lt;/li&gt;
&lt;li&gt;Identifying resistance spread&lt;/li&gt;
&lt;li&gt;Guiding resource allocation&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The complexities of complexity of infection are worth mastering—because behind every statistic is a person, and behind every person is a network of transmission we&amp;rsquo;re working to interrupt.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;further-reading&#34;&gt;Further Reading&lt;/h2&gt;
&lt;p&gt;&lt;strong&gt;Key Papers:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Chang HH, et al. (2017). &amp;ldquo;THE REAL McCOIL: A method for the concurrent estimation of the complexity of infection and SNP allele frequency for malaria parasites.&amp;rdquo; &lt;em&gt;PLoS Computational Biology&lt;/em&gt;.&lt;/li&gt;
&lt;li&gt;Manske M, et al. (2012). &amp;ldquo;Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing.&amp;rdquo; &lt;em&gt;Nature&lt;/em&gt;.&lt;/li&gt;
&lt;li&gt;Nkhoma SC, et al. (2013). &amp;ldquo;Population genetic correlates of declining transmission in a human pathogen.&amp;rdquo; &lt;em&gt;Molecular Ecology&lt;/em&gt;.&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Software:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/EPPIcenter/THEREALMcCOIL&#34;&gt;THE REAL McCOIL&lt;/a&gt; - R package for COI estimation&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/bahlolab/moimix&#34;&gt;moimix&lt;/a&gt; - Alternative Bayesian approach&lt;/li&gt;
&lt;li&gt;&lt;a href=&#34;https://github.com/EPPIcenter/dcifer&#34;&gt;dcifer&lt;/a&gt; - Identity-by-descent based COI&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Workshops:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Applied Malaria Molecular Surveillance (AMMS) - Annual workshop covering COI methods&lt;/li&gt;
&lt;li&gt;Materials available at: &lt;a href=&#34;https://www.eppicenter.org&#34;&gt;AMMS Practicals&lt;/a&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Post drafted with assistance from Claude.AI&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>The Network Effect: Why Some Disease Outbreaks Are Predictable and Others Are Coin Flips</title>
      <link>https://nicholasbrazeau.com/2024/11/13/the-network-effect-why-some-disease-outbreaks-are-predictable-and-others-are-coin-flips/</link>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2024/11/13/the-network-effect-why-some-disease-outbreaks-are-predictable-and-others-are-coin-flips/</guid>
      <description>&lt;h2 id=&#34;the-forecasting-problem&#34;&gt;The Forecasting Problem&lt;/h2&gt;
&lt;p&gt;When COVID-19 emerged in early 2020, epidemiologists raced to answer a critical question: How many people will ultimately get infected? Despite sophisticated models and massive computing power, predictions varied wildly. Some forecasts missed by orders of magnitude. A question that arose is &lt;strong&gt;does network structure even matter for prediction? If so, which features matter most?&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;After analyzing 1.35 million epidemic simulations across 1,650 unique scenarios, we found surprising relationships.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-45-fold-difference&#34;&gt;The 45-Fold Difference&lt;/h2&gt;
&lt;p&gt;The single most important finding from our research: &lt;strong&gt;Network heterogeneity—the presence of &amp;ldquo;hubs&amp;rdquo; with many contacts—improves epidemic predictability by up to 45-fold compared to networks where everyone has the same number of contacts.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;Let me put that in concrete terms:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;In homogeneous networks&lt;/strong&gt; (everyone has ~20 contacts): Our predictions were off by an average of 72 people in a population of 1,000. Prediction error: 7.2%&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;In heterogeneous networks&lt;/strong&gt; (some hubs, some regular people): Our predictions were off by just 3 people. Prediction error: 0.3%&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;That&amp;rsquo;s not a marginal improvement. That&amp;rsquo;s the difference between a confident forecast and an educated guess.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;why-hubs-change-everything&#34;&gt;Why Hubs Change Everything&lt;/h2&gt;
&lt;p&gt;Degree distribution and heterogeneity are the &amp;ldquo;temperature and pressure&amp;rdquo; of epidemic prediction.&lt;/p&gt;
&lt;p&gt;Our research quantifies exactly how much each network feature matters:&lt;/p&gt;
&lt;table&gt;
&lt;thead&gt;
&lt;tr&gt;
&lt;th&gt;Network Feature&lt;/th&gt;
&lt;th&gt;Predictability (CV)&lt;/th&gt;
&lt;th&gt;Relative Impact&lt;/th&gt;
&lt;/tr&gt;
&lt;/thead&gt;
&lt;tbody&gt;
&lt;tr&gt;
&lt;td&gt;Degree heterogeneity&lt;/td&gt;
&lt;td&gt;0.287&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Best&lt;/strong&gt; (3× better than modularity)&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Clustering&lt;/td&gt;
&lt;td&gt;0.577&lt;/td&gt;
&lt;td&gt;Intermediate&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Temporal dynamics&lt;/td&gt;
&lt;td&gt;0.806&lt;/td&gt;
&lt;td&gt;Weak&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
&lt;td&gt;Modularity&lt;/td&gt;
&lt;td&gt;0.822&lt;/td&gt;
&lt;td&gt;&lt;strong&gt;Worst&lt;/strong&gt; (3× worse than degree)&lt;/td&gt;
&lt;/tr&gt;
&lt;/tbody&gt;
&lt;/table&gt;
&lt;p&gt;CV (coefficient of variation) measures unpredictability—lower is more predictable. The 3-fold difference between degree heterogeneity and modularity tells us to prioritize measuring the right things.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;when-predictions-work-and-when-they-dont&#34;&gt;When Predictions Work (and When They Don&amp;rsquo;t)&lt;/h2&gt;
&lt;p&gt;Not all epidemics are equally predictable. We found that &lt;strong&gt;predictability varies 18-fold&lt;/strong&gt; depending on transmission characteristics:&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Highly Predictable Scenarios:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;High transmission rates (10% infection risk per contact per day)&lt;/li&gt;
&lt;li&gt;Long infectious periods (15 days)&lt;/li&gt;
&lt;li&gt;Heterogeneous networks with clear hubs&lt;/li&gt;
&lt;li&gt;Result: Prediction error &amp;lt; 1 person (0.1% of population)&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Essentially Random Scenarios:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Low transmission rates (0.5% per contact per day)&lt;/li&gt;
&lt;li&gt;Short infectious periods (3 days)&lt;/li&gt;
&lt;li&gt;Modular or homogeneous networks&lt;/li&gt;
&lt;li&gt;Result: Prediction error &amp;gt; 100 people (10% of population)&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-80-20-rule-of-disease-spread&#34;&gt;The 80-20 Rule of Disease Spread&lt;/h2&gt;
&lt;p&gt;In heterogeneous networks, we consistently observed:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;20% of individuals&lt;/strong&gt; (hubs) have &lt;strong&gt;80% of contacts&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;Those 20% cause &lt;strong&gt;~80% of transmission events&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;This is &lt;strong&gt;structural&lt;/strong&gt; (determined by network position), not random&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;This is a game-changer for intervention strategies. Vaccinating people randomly provides linear benefit: vaccinate 20% of people, prevent 20% of infections. But vaccinating the top 20% by degree prevents 60% of infections—three times the impact.&lt;/p&gt;
&lt;p&gt;The challenge, of course, is identifying hubs. But that&amp;rsquo;s exactly what our research shows we should prioritize measuring.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;one-million-simulations-the-computational-scale&#34;&gt;One Million Simulations: The Computational Scale&lt;/h2&gt;
&lt;p&gt;This is one of the largest systematic investigations of network effects on epidemics ever conducted:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;1.35 million&lt;/strong&gt; stochastic epidemic simulations&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;1,650&lt;/strong&gt; unique parameter combinations&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;6&lt;/strong&gt; network manipulation types tested&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;25&lt;/strong&gt; transmission scenarios (5 rates × 5 durations)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;100&lt;/strong&gt; replicates per scenario for statistical power&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;93 GB&lt;/strong&gt; of simulation data analyzed&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;We started with 10 baseline networks (1,000 people, 20 contacts each), then systematically manipulated:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;Degree Distribution&lt;/strong&gt; — Created hubs with 80+ contacts using stick-breaking process&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Modularity&lt;/strong&gt; — Built community structure (separate friend groups)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Clustering&lt;/strong&gt; — Added triangles (&amp;ldquo;friend-of-friend&amp;rdquo; connections)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Unity&lt;/strong&gt; — Broke down community barriers&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Dynamicity&lt;/strong&gt; — Added temporal rewiring (people change contacts over time)&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Baseline&lt;/strong&gt; — Control networks with no manipulation&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;Each simulation ran a stochastic SIR (Susceptible-Infected-Recovered) model using the Gillespie algorithm for exact event-driven dynamics. We then compared predictions from Newman&amp;rsquo;s analytical framework against actual simulated outcomes.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;when-simple-math-beats-complex-simulations&#34;&gt;When Simple Math Beats Complex Simulations&lt;/h2&gt;
&lt;p&gt;One of our most validating findings: &lt;strong&gt;Newman&amp;rsquo;s analytical predictions are remarkably accurate for heterogeneous networks.&lt;/strong&gt;&lt;/p&gt;
&lt;p&gt;When degree variance is present:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Mean Absolute Error &amp;lt; 5 people (0.5% of population)&lt;/li&gt;
&lt;li&gt;Correlation between theory and simulation: r &amp;gt; 0.95&lt;/li&gt;
&lt;li&gt;Works best at moderate-to-high transmission rates&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;When degree variance is absent (homogeneous networks):&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Mean Absolute Error &amp;gt; 50 people (5% of population)&lt;/li&gt;
&lt;li&gt;Theory and simulation diverge&lt;/li&gt;
&lt;li&gt;Even simulations show high variance across runs&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The pattern is striking: &lt;strong&gt;Newman&amp;rsquo;s accuracy inversely correlates with outcome unpredictability&lt;/strong&gt; (r = -0.85, p &amp;lt; 0.01). When epidemics are inherently predictable (heterogeneous networks), simple analytical methods work beautifully. When epidemics are inherently random (homogeneous/modular networks), even complex simulations struggle.&lt;/p&gt;
&lt;p&gt;This suggests a practical heuristic: If your analytical model is failing, it might not be because the model is wrong—it might be because the epidemic is genuinely unpredictable given available data.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;surprising-finding-network-dynamics-dont-matter-much&#34;&gt;Surprising Finding: Network Dynamics Don&amp;rsquo;t Matter Much&lt;/h2&gt;
&lt;p&gt;We expected temporal dynamics—people changing who they interact with over time—to strongly affect predictability. We were wrong.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;When node-level degrees stay constant:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Static networks: CV = 0.810&lt;/li&gt;
&lt;li&gt;Dynamic networks (rewiring edges): CV = 0.806&lt;/li&gt;
&lt;li&gt;Virtually no difference&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;strong&gt;Implication:&lt;/strong&gt; Static network snapshots may be sufficient for most epidemic models, as long as you accurately capture the degree distribution. You don&amp;rsquo;t need expensive longitudinal contact tracing if you can measure degree heterogeneity at a single point in time.&lt;/p&gt;
&lt;p&gt;This is enormously practical. Longitudinal contact network data is expensive and invasive to collect. Our results suggest that investing in accurate degree measurements at one timepoint may be more valuable than tracking changing contacts over time.&lt;/p&gt;
&lt;h2 id=&#34;about-the-research&#34;&gt;About the Research&lt;/h2&gt;
&lt;p&gt;This work was conducted using custom-built simulation infrastructure implementing event-driven stochastic SIR models on structured contact networks. The research combines insights from network science, percolation theory, stochastic processes, and computational epidemiology.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Key Methods:&lt;/strong&gt;&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Gillespie algorithm for exact stochastic simulation&lt;/li&gt;
&lt;li&gt;Newman&amp;rsquo;s probability generating function framework for analytical predictions&lt;/li&gt;
&lt;li&gt;Configuration model for network generation with specified degree distributions&lt;/li&gt;
&lt;li&gt;1.35 million simulations across 1,650 parameter combinations&lt;/li&gt;
&lt;li&gt;Kullback-Leibler divergence and Mean Absolute Error for accuracy assessment&lt;/li&gt;
&lt;/ul&gt;
&lt;hr&gt;
&lt;p&gt;&lt;em&gt;Post drafted with assistance from Claude.AI&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Using Statistical Modeling to Win a NFL Knockout Pool</title>
      <link>https://nicholasbrazeau.com/2024/11/13/using-statistical-modeling-to-win-a-nfl-knockout-pool/</link>
      <pubDate>Wed, 13 Nov 2024 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2024/11/13/using-statistical-modeling-to-win-a-nfl-knockout-pool/</guid>
      <description>&lt;h2 id=&#34;introduction&#34;&gt;Introduction&lt;/h2&gt;
&lt;p&gt;Admittedly, I am a terrible sports fan. However, I do enjoy competition and the opportunity to participate in a little &amp;ldquo;smack talk&amp;rdquo; with family and friends.&lt;/p&gt;
&lt;p&gt;Every year, family, friends, and folks from my childhood community come together to play a game of &lt;strong&gt;NFL Pool Knockout&lt;/strong&gt;. The rules are deceptively simple:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;Each participant picks &lt;strong&gt;one NFL team each week&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;If your team &lt;strong&gt;wins&lt;/strong&gt;, you advance to the next week&lt;/li&gt;
&lt;li&gt;If your team &lt;strong&gt;loses or ties&lt;/strong&gt;, you&amp;rsquo;re eliminated&lt;/li&gt;
&lt;li&gt;Each team can only be selected &lt;strong&gt;once during the season&lt;/strong&gt;&lt;/li&gt;
&lt;li&gt;Last person standing wins&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;Sounds simple, right? The strategy, however, is surprisingly complex.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-complexity-problem&#34;&gt;The Complexity Problem&lt;/h2&gt;
&lt;p&gt;At first glance, you might think: &amp;ldquo;Just pick the best team each week!&amp;rdquo; But there&amp;rsquo;s a catch—once you use a team, you can&amp;rsquo;t use them again. This creates a classic &lt;strong&gt;resource allocation problem&lt;/strong&gt; under uncertainty.&lt;/p&gt;
&lt;p&gt;Consider the mathematical scale:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;18 weeks in an NFL season&lt;/li&gt;
&lt;li&gt;32 teams available&lt;/li&gt;
&lt;li&gt;Number of possible strategies: &lt;strong&gt;18! ≈ 6.4 × 10¹⁵&lt;/strong&gt;&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;That&amp;rsquo;s 6.4 quadrillion possible ways to order your picks. You can&amp;rsquo;t evaluate them all.&lt;/p&gt;
&lt;h3 id=&#34;the-strategic-dilemma&#34;&gt;The Strategic Dilemma&lt;/h3&gt;
&lt;p&gt;Should you:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Burn your best teams early&lt;/strong&gt; to guarantee survival through the early weeks?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Save elite teams for late&lt;/strong&gt; when fewer opponents remain?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Balance risk across the season&lt;/strong&gt; with a mix of safe and risky picks?&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;The answer depends on:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;&lt;strong&gt;Team strength&lt;/strong&gt; — Who&amp;rsquo;s actually good?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Schedule strength&lt;/strong&gt; — Who do they play each week?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Bye weeks&lt;/strong&gt; — When are teams not playing?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Opponent strategy&lt;/strong&gt; — What are others likely to pick?&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Variance&lt;/strong&gt; — How unpredictable are the outcomes?&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;This is where statistics comes in.&lt;/p&gt;
&lt;hr&gt;
&lt;h2 id=&#34;the-statistical-approach&#34;&gt;The Statistical Approach&lt;/h2&gt;
&lt;p&gt;I built an R package called &lt;a href=&#34;https://github.com/nickbrazeau/nflKOSA&#34;&gt;&lt;code&gt;nflKOSA&lt;/code&gt;&lt;/a&gt; (NFL Knockout Simulated Annealing) to solve this optimization problem. The package focuses on the core challenge: &lt;strong&gt;given win probabilities for each matchup, find the optimal sequence of team selections&lt;/strong&gt;.&lt;/p&gt;
&lt;h3 id=&#34;simulated-annealing-optimization&#34;&gt;Simulated Annealing Optimization&lt;/h3&gt;
&lt;p&gt;Once we have win probabilities for every matchup, we need to find the optimal sequence of team selections across 18 weeks. This is a &lt;strong&gt;combinatorial optimization problem&lt;/strong&gt; that&amp;rsquo;s too large for brute force.&lt;/p&gt;
&lt;p&gt;&lt;strong&gt;Simulated Annealing&lt;/strong&gt; is a probabilistic optimization algorithm inspired by metallurgy (the process of slowly cooling metal to minimize defects). Here&amp;rsquo;s how it works:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Start with a random strategy (sequence of team picks)&lt;/li&gt;
&lt;li&gt;Calculate the &amp;ldquo;energy&amp;rdquo; (expected number of weeks survived)&lt;/li&gt;
&lt;li&gt;Propose a small change (swap two team selections)&lt;/li&gt;
&lt;li&gt;If the new strategy is better, accept it&lt;/li&gt;
&lt;li&gt;If the new strategy is worse, sometimes accept it anyway (with probability based on &amp;ldquo;temperature&amp;rdquo;)&lt;/li&gt;
&lt;li&gt;Slowly reduce the &amp;ldquo;temperature&amp;rdquo; to converge on an optimum&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;The key insight: &lt;strong&gt;accepting worse solutions early prevents getting stuck in local optima.&lt;/strong&gt; By occasionally accepting suboptimal moves, the algorithm can escape local peaks and find the global maximum.&lt;/p&gt;
&lt;h3 id=&#34;evaluating-strategies&#34;&gt;Evaluating Strategies&lt;/h3&gt;
&lt;p&gt;Each strategy is evaluated by calculating the &lt;strong&gt;expected weeks survived&lt;/strong&gt;. For a given sequence of team picks, this is:&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;Expected Weeks = Σ P(survive to week w)
               = Σ Π(win probability for weeks 1 through w)
&lt;/code&gt;&lt;/pre&gt;&lt;p&gt;The simulated annealing algorithm maximizes this objective by:&lt;/p&gt;
&lt;ol&gt;
&lt;li&gt;Starting with a random team selection sequence&lt;/li&gt;
&lt;li&gt;Using the &lt;code&gt;cost()&lt;/code&gt; function to evaluate the strategy (negative expected weeks)&lt;/li&gt;
&lt;li&gt;Using the &lt;code&gt;proposal()&lt;/code&gt; function to generate alternative strategies&lt;/li&gt;
&lt;li&gt;Accepting improvements and occasionally accepting worse solutions&lt;/li&gt;
&lt;li&gt;Cooling the temperature parameter to converge on the optimum&lt;/li&gt;
&lt;/ol&gt;
&lt;p&gt;The optimization returns:&lt;/p&gt;
&lt;ul&gt;
&lt;li&gt;&lt;strong&gt;Optimal team sequence&lt;/strong&gt; — Which team to pick each week&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Expected survival&lt;/strong&gt; — Based on the product of win probabilities&lt;/li&gt;
&lt;li&gt;&lt;strong&gt;Final cost&lt;/strong&gt; — Negative expected weeks survived&lt;/li&gt;
&lt;/ul&gt;
&lt;p&gt;&lt;em&gt;Post drafted with assistance from Claude.AI&lt;/em&gt;&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context</title>
      <link>https://nicholasbrazeau.com/publication/sheppard-zambia-2023/</link>
      <pubDate>Thu, 29 Jun 2023 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/sheppard-zambia-2023/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Selective sweep suggests transcriptional regulation may underlie Plasmodium vivax resilience to malaria control measures in Cambodia - PubMed</title>
      <link>https://nicholasbrazeau.com/publication/noauthor-selective-nodate/</link>
      <pubDate>Sat, 30 Jul 2022 19:35:38 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/noauthor-selective-nodate/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Statistical Modeling with Serologic Data</title>
      <link>https://nicholasbrazeau.com/2022/05/20/covid-19-statistical-modeling-with-serologic-data/</link>
      <pubDate>Fri, 20 May 2022 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2022/05/20/covid-19-statistical-modeling-with-serologic-data/</guid>
      <description>&lt;p&gt;The purpose of the &lt;code&gt;COVIDCurve&lt;/code&gt; project and R-software package was to provide a framework to fit age-specific infection fatality ratios (IFRs) in an epidemic that is using serologic data to estimate prevalence. The model was originally designed in response to the COVID-19 pandemic (hence the name) but is broadly applicable.&lt;/p&gt;
&lt;p&gt;Accurate inference of the IFR based on serological data is challenging due to a number of factors that can bias estimates away from the true value, including: (1) the delay between infection and death, (2) the dynamical process of seroconversion and seroreversion, (3) potential differences in age-specific attack rates, and (4) serological test characteristics. These delay-distributions and serologic test characteristics are expected to cause both shifts in when deaths are observed as well as when and how many true infections are observed, which will then affect the IFR.&lt;/p&gt;
&lt;p&gt;The model used in &lt;code&gt;COVIDCurve&lt;/code&gt; can be briefly summarized as having two pieces: (1) an infection curve shape that is informed by the shape the of the observed death curve but &amp;ldquo;thrown&amp;rdquo;&amp;quot; backwards in time; (2) a pin or a point on the y-axis that the shape must go through (i.e. a pin to inform the area under the curve, or cumulative infections). This pin is informed by the observed serologic data, accounting for test characteristics (e.g. sensitivity and specificity) as well as the time from infection to seroconversion and seroreversion. Accounting for seroreversion, or the waning of antibodies over time that then produces a false negative test, becomes increasingly important as epidemics progress and/or as daily infections start to contract.&lt;/p&gt;
&lt;p&gt;This work is further described as &lt;a href=&#34;https://go.nature.com/3KByzI4&#34;&gt;Nature Communities blog post&lt;/a&gt; and is published in &lt;a href=&#34;https://www.nature.com/articles/s43856-022-00106-7&#34;&gt;Communications Medicine&lt;/a&gt;.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>AMR in the Hospital</title>
      <link>https://nicholasbrazeau.com/project/sepidapto/</link>
      <pubDate>Thu, 19 May 2022 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/sepidapto/</guid>
      <description>&lt;p&gt;In this case study of a patient with &lt;em&gt;Staphylococcus epidermidis&lt;/em&gt; bacteremia receiving prolonged antibiotics that developed Daptomycin resistance, we used whole genome sequencing and bioinformatic analyses to identify a novel mutation. This project demonstrated the utility in using genomic analysis for the identification and survelliance of putative antimicrobial resistant mutations. This project was published as Brazeau &amp;amp; Levinson &lt;em&gt;et al.&lt;/em&gt; 2020 in Evolution, Medicine, and Public Health&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Brazeau NF, Levinson KJ, Schranz A, Moser KA, Hollis I, Iyer P, Chien C, Bowen A, van Duin D, Lachiewicz A, Andermann T, Jones M, Miller M, Juliano JJ, Bartelt LA. Loss of daptomycin susceptibility in clinical Staphylococcus epidermidis infection coincided with variants in WalK. Evol Med Public Health. 2020 Sep 7;2020(1):219-224. doi: 10.1093/emph/eoaa031. PMID: 33214904; PMCID: PMC7658547.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Antimalarial Resistance in Ethiopia</title>
      <link>https://nicholasbrazeau.com/project/ephiamr/</link>
      <pubDate>Thu, 19 May 2022 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/ephiamr/</guid>
      <description>&lt;p&gt;Using samples collected as part of antimalarial drug efficacy studies across Ethiopia over multiple years, we demonstrated that &lt;em&gt;P. falciparum&lt;/em&gt; parasites have evidence of persistence through space and time, despite differing profiles of antimalarial resistance. A main focus of this project was capacity building and increased molecular surveillance capacity at the Ethiopian Public Health Institute and was the first project of a lasting collaboration between the EPHI and UNC. This project was published in the American Journal of Tropical Medicine &amp;amp; Hygeine&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Brazeau NF, Assefa A, Mohammed H, Seme H, Tsadik AG, Parr JB, Keeler C, Hathaway NJ, Meshnick SR, Bailey JA, Kassa M, Juliano JJ, Woyessa A. Pooled Deep Sequencing of Drug Resistance Loci from Plasmodium falciparum Parasites across Ethiopia. Am J Trop Med Hyg. 2019 Nov;101(5):1139-1143. doi: 10.4269/ajtmh.19-0142. PMID: 31516103; PMCID: PMC6838589.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>COVID19 IFR Re-estimation</title>
      <link>https://nicholasbrazeau.com/project/reestimateifr/</link>
      <pubDate>Thu, 19 May 2022 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/reestimateifr/</guid>
      <description>&lt;p&gt;For a summary of these early re-estimates of the COVID-19 first wave infection fatality ratio estimates accounting for seroreversion, please see the associated &lt;a href=&#34;https://www.imperial.ac.uk/news/207273/covid19-deaths-infection-fatality-ratio-says/&#34;&gt;press release&lt;/a&gt; that accompanied Report 34&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Brazeau NF, Verity R, Jenks S, Fu H, Whittaker C, Winskill P, Dorigatti I, Walker PGT, Riley S, Schnekenberg RP, Hoeltgebaum H, Mellan TA, Mishra S, Unwin HJT, Watson OJ, Cucunubá ZM, Baguelin M, Whittles L, Bhatt S, Ghani AC, Ferguson NM, Okell LC.. Report 34 - COVID-19 Infection Fatality Ratio Estimates from Seroprevalence. October 2020. &lt;a href=&#34;https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr&#34;&gt;https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr&lt;/a&gt;.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Reassessing Reported Deaths and Estimated Infection Attack Rate during the First 6 Months of the COVID-19 Epidemic, Delhi, India</title>
      <link>https://nicholasbrazeau.com/publication/pons-salort-reassessing-2022/</link>
      <pubDate>Fri, 01 Apr 2022 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/pons-salort-reassessing-2022/</guid>
      <description></description>
    </item>
    
    <item>
      <title>`DISCent`: Spatial Inbreeding Estimation</title>
      <link>https://nicholasbrazeau.com/project/discent/</link>
      <pubDate>Wed, 09 Mar 2022 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/discent/</guid>
      <description>&lt;p&gt;This is a simple package with a single function that runs a simple isolation by distance and identity by descent model for producing deme inbreeding spatial coefficients (DISCs). By theory, genetic relatnedness is strictly limited to measure of identity by descent. For a full mathematical overview of the simple model, please see the supplements from Brazeau et al. 2022 in in preperation&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;p&gt;Briefly, in the early 1970s, Malécot described a relationship between genetic relatedness and physical distance under the premise that pairs that are far apart are less likely to mate: isolation by distance. Capitalizing on this framework by using measures of identity by descent (IBD), we produce a deme inbreeding spatial coefficient (DISC) for point process data in continuous space. Essentially, this measure estimates the amount of &amp;ldquo;inbreeding&amp;rdquo; or within deme relatedness under the assumption that relatedness between two locations in space can be measured from the average pairwise IBD between those two locations conditional on the physical distance that separates them. Further, we assume that geographic distance is scaled by a migration rate, which is a global parameter among all spatial locations (i.e. the migration rate is assumed to be constant through space). As a result, the model produces a DISC for each spatial location considered (user defined) and an overall migration rate parameter (m). Parameter optimization is achieved with a &amp;ldquo;vanilla&amp;rdquo; gradient descent algorithm. Given that &amp;ldquo;vanilla&amp;rdquo; gradient descent is used, we recommend running numerous models from a wide of array of start parameters to ensure that your final results are the global maximum and not a local maximum (i.e. a false peak).&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Nicholas F Brazeau, &lt;em&gt;in preparation&lt;/em&gt;.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-estimating-2022/</link>
      <pubDate>Sat, 01 Jan 2022 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-estimating-2022/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Household Prevalence of Plasmodium falciparum, Plasmodium vivax, and Plasmodium ovale in the Democratic Republic of the Congo, 2013-2014</title>
      <link>https://nicholasbrazeau.com/publication/mitchell-household-2021/</link>
      <pubDate>Wed, 01 Dec 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/mitchell-household-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Vivax in the DRC</title>
      <link>https://nicholasbrazeau.com/project/drcpv/</link>
      <pubDate>Wed, 07 Jul 2021 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/drcpv/</guid>
      <description>&lt;p&gt;&lt;em&gt;P. vivax&lt;/em&gt; has long been assumed to be essentially extinct in Sub-Saharan Africa. In this manuscript, we combine techniques from causal inference epidemiolgy, spatial epidemiology, and bioinformatics to describes who is being infected by &lt;em&gt;P. vivax&lt;/em&gt; in the DRC, where infections are occurring, and where the infections potentially originated. Overall, we suggest that &lt;em&gt;P. vivax&lt;/em&gt; is persisting in the DRC rather than expanding or thriving. This project was published as Brazeau &lt;em&gt;et al.&lt;/em&gt; 2021 in Nature Communications&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Brazeau NF, Mitchell CL, Morgan AP, Deutsch-Feldman M, Watson OJ, Thwai KL, Gelabert P, van Dorp L, Keeler CY, Waltmann A, Emch M, Gartner V, Redelings B, Wray GA, Mwandagalirwa MK, Tshefu AK, Likwela JL, Edwards JK, Verity R, Parr JB, Meshnick SR, Juliano JJ. The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo. Nat Commun. 2021 Jul 7;12(1):4169. doi: 10.1038/s41467-021-24216-3. PMID: 34234124; PMCID: PMC8263614.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Modelling intensive care unit capacity under different epidemiological scenarios of the COVID-19 pandemic in three Western European countries</title>
      <link>https://nicholasbrazeau.com/publication/mccabe-modelling-2021/</link>
      <pubDate>Thu, 01 Jul 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/mccabe-modelling-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-epidemiology-2021/</link>
      <pubDate>Thu, 01 Jul 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-epidemiology-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Burden of Malaria in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/deutsch-feldman-burden-2021/</link>
      <pubDate>Tue, 01 Jun 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/deutsch-feldman-burden-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Using syndromic measures of mortality to capture the dynamics of COVID-19 in Java, Indonesia, in the context of vaccination rollout</title>
      <link>https://nicholasbrazeau.com/publication/djaafara-using-2021/</link>
      <pubDate>Tue, 01 Jun 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/djaafara-using-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Within-country age-based prioritisation, global allocation, and public health impact of a vaccine against SARS-CoV-2: A mathematical modelling analysis</title>
      <link>https://nicholasbrazeau.com/publication/hogan-within-country-2021/</link>
      <pubDate>Sat, 01 May 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/hogan-within-country-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Leveraging community mortality indicators to infer COVID-19 mortality and transmission dynamics in Damascus, Syria</title>
      <link>https://nicholasbrazeau.com/publication/watson-leveraging-2021/</link>
      <pubDate>Thu, 01 Apr 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/watson-leveraging-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Under the Radar: Epidemiology of Plasmodium ovale in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/mitchell-under-2021/</link>
      <pubDate>Mon, 01 Mar 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/mitchell-under-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Reduction in mobility and COVID-19 transmission</title>
      <link>https://nicholasbrazeau.com/publication/nouvellet-reduction-2021/</link>
      <pubDate>Mon, 01 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/nouvellet-reduction-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Selection of Cytochrome b Mutants Is Rare among Plasmodium falciparum Patients Failing Treatment with Atovaquone-Proguanil in Cambodia</title>
      <link>https://nicholasbrazeau.com/publication/lin-selection-2021/</link>
      <pubDate>Mon, 01 Feb 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/lin-selection-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Database of epidemic trends and control measures during the first wave of COVID-19 in mainland China</title>
      <link>https://nicholasbrazeau.com/publication/fu-database-2021/</link>
      <pubDate>Fri, 01 Jan 2021 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/fu-database-2021/</guid>
      <description></description>
    </item>
    
    <item>
      <title>COVID-19 Infection Fatality Ratio: Where we started, Where we were, Where we are</title>
      <link>https://nicholasbrazeau.com/talk/ighid-covid-19-talk/</link>
      <pubDate>Fri, 18 Dec 2020 09:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/talk/ighid-covid-19-talk/</guid>
      <description>


&lt;p&gt;Talk at the UNC Institute of Global Health and Infectious Disease monthly conference. The talk was early discussion of statistical modeling and the the evolution of the COVID-19 IFR during the first wave of the pandemic. Our statistical model is now published at Communications Medicine&lt;a href=&#34;#fn1&#34; class=&#34;footnote-ref&#34; id=&#34;fnref1&#34;&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/a&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes footnotes-end-of-document&#34;&gt;
&lt;hr /&gt;
&lt;ol&gt;
&lt;li id=&#34;fn1&#34;&gt;&lt;p&gt;Brazeau NF, Verity R, Jenks S, Fu H, Whittaker C, Winskill P, Dorigatti I, Walker PGT, Riley S, Schnekenberg RP, Hoeltgebaum H, Mellan TA, Mishra S, Unwin HJT, Watson OJ, Cucunubá ZM, Baguelin M, Whittles L, Bhatt S, Ghani AC, Ferguson NM, Okell LC. Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling. Commun Med (Lond). 2022 May 19;2:54. doi: 10.1038/s43856-022-00106-7. PMID: 35603270; PMCID: PMC9120146.&lt;a href=&#34;#fnref1&#34; class=&#34;footnote-back&#34;&gt;↩︎&lt;/a&gt;&lt;/p&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study</title>
      <link>https://nicholasbrazeau.com/publication/grassly-comparison-2020/</link>
      <pubDate>Tue, 01 Dec 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/grassly-comparison-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>SARS-CoV-2 infection prevalence on repatriation flights from Wuhan City, China</title>
      <link>https://nicholasbrazeau.com/publication/thompson-sars-cov-2-2020/</link>
      <pubDate>Tue, 01 Dec 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/thompson-sars-cov-2-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>State-level tracking of COVID-19 in the United States</title>
      <link>https://nicholasbrazeau.com/publication/unwin-state-level-2020/</link>
      <pubDate>Tue, 01 Dec 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/unwin-state-level-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Spatial Patterns of Falciparum Malaria Genetic Relatedness Driven by Human Movement in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/talk/discent-astmh/</link>
      <pubDate>Mon, 16 Nov 2020 08:00:00 -0800</pubDate>
      <guid>https://nicholasbrazeau.com/talk/discent-astmh/</guid>
      <description>


&lt;p&gt;Remote presentation at the annual American Society of Tropical Medicine and Hygiene conference. Presented early work on the Deme Inbreeding Spatial Coefficient framework and the &lt;code&gt;DISCent&lt;/code&gt; R-package. This project is currently in preparation.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>`COVIDCurve`: COVID-19 Statistical Modeling</title>
      <link>https://nicholasbrazeau.com/project/covidcurve/</link>
      <pubDate>Thu, 29 Oct 2020 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/covidcurve/</guid>
      <description>&lt;p&gt;The purpose of this package is to provide a framework to fit age-specific infection fatality ratios (IFRs) in an epidemic that is using serologic data to estimate prevalence. The model was originally designed in response to the COVID-19 pandemic (hence the name) but is broadly applicable.
Accurate inference of the IFR based on serological data is challenging due to a number of factors that can bias estimates away from the true value, including: (1) the delay between infection and death, (2) the dynamical process of seroconversion and seroreversion, (3) potential differences in age-specific attack rates, and (4) serological test characteristics. These delay-distributions and serologic test characteristics are expected to cause both shifts in when deaths are observed as well as when and how many true infections are observed, which will then affect the IFR.
The model used in &lt;code&gt;COVIDCurve&lt;/code&gt; can be briefly summarized as having two pieces: (1) an infection curve shape that is informed by the shape the of the observed death curve but &amp;ldquo;thrown&amp;rdquo;&amp;quot; backwards in time; (2) a pin or a point on the y-axis that the shape must go through (i.e. a pin to inform the area under the curve, or cumulative infections). This pin is informed by the observed serologic data, accounting for test characteristics (e.g. sensitivity and specificity) as well as the time from infection to seroconversion and seroreversion. Accounting for seroreversion, or the waning of antibodies over time that then produces a false negative test, becomes increasingly important as epidemics progress and/or as daily infections start to contract.&lt;/p&gt;
&lt;p&gt;The IFR estimates from this model (&lt;a href=&#34;https://github.com/mrc-ide/reestimate_covidIFR_analysis&#34;&gt;code repo&lt;/a&gt;) were published as Imperial College London COVID-19 Response Team Report 34&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;. The methodological approach for the model was published as a separate manuscript in Communications Medicine &lt;sup id=&#34;fnref:2&#34;&gt;&lt;a href=&#34;#fn:2&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;2&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Brazeau NF, Verity R, Jenks S, Fu H, Whittaker C, Winskill P, Dorigatti I, Walker PGT, Riley S, Schnekenberg RP, Hoeltgebaum H, Mellan TA, Mishra S, Unwin HJT, Watson OJ, Cucunubá ZM, Baguelin M, Whittles L, Bhatt S, Ghani AC, Ferguson NM, Okell LC.. Report 34 - COVID-19 Infection Fatality Ratio Estimates from Seroprevalence. October 2020. &lt;a href=&#34;https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr&#34;&gt;https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr&lt;/a&gt;.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;li id=&#34;fn:2&#34;&gt;
&lt;p&gt;Brazeau NF, Verity R, Jenks S, Fu H, Whittaker C, Winskill P, Dorigatti I, Walker PGT, Riley S, Schnekenberg RP, Hoeltgebaum H, Mellan TA, Mishra S, Unwin HJT, Watson OJ, Cucunubá ZM, Baguelin M, Whittles L, Bhatt S, Ghani AC, Ferguson NM, Okell LC. Estimating the COVID-19 infection fatality ratio accounting for seroreversion using statistical modelling. Commun Med (Lond). 2022 May 19;2:54. doi: 10.1038/s43856-022-00106-7. PMID: 35603270; PMCID: PMC9120146.&amp;#160;&lt;a href=&#34;#fnref:2&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Response to COVID-19 in South Korea and implications for lifting stringent interventions</title>
      <link>https://nicholasbrazeau.com/publication/dighe-response-2020/</link>
      <pubDate>Thu, 01 Oct 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/dighe-response-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study</title>
      <link>https://nicholasbrazeau.com/publication/hogan-potential-2020/</link>
      <pubDate>Tue, 01 Sep 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/hogan-potential-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The impact of COVID-19 and strategies for mitigation and suppression in low- and middle-income countries</title>
      <link>https://nicholasbrazeau.com/publication/walker-impact-2020/</link>
      <pubDate>Wed, 01 Jul 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/walker-impact-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Spatial and epidemiological drivers of Plasmodium falciparum malaria among adults in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/deutsch-feldman-spatial-2020/</link>
      <pubDate>Mon, 01 Jun 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/deutsch-feldman-spatial-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>`polySimIBD`: A Simple Malaria Genetic Model</title>
      <link>https://nicholasbrazeau.com/project/polysimibd/</link>
      <pubDate>Thu, 30 Apr 2020 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/polysimibd/</guid>
      <description>&lt;p&gt;The goal of polySimIBD is to perform forwards in-time simulation of malaria population genetics. The model uses a discrete-time, discrete-loci structured Wright Fisher approximation to account for (simplified) malaria transmission dynamics and can be parameterized across demes to include a spatial component.&lt;/p&gt;
&lt;p&gt;The model was originally used in Verity &amp;amp; Aydemir &amp;amp; Brazeau &lt;em&gt;et al.&lt;/em&gt; 2020 in Nature Communications&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt; to assess the bias in our identity by descent calculation.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Verity R, Aydemir O, Brazeau NF, Watson OJ, Hathaway NJ, Mwandagalirwa MK, Marsh PW, Thwai K, Fulton T, Denton M, Morgan AP, Parr JB, Tumwebaze PK, Conrad M, Rosenthal PJ, Ishengoma DS, Ngondi J, Gutman J, Mulenga M, Norris DE, Moss WJ, Mensah BA, Myers-Hansen JL, Ghansah A, Tshefu AK, Ghani AC, Meshnick SR, Bailey JA, Juliano JJ. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat Commun. 2020 Apr 30;11(1):2107. doi: 10.1038/s41467-020-15779-8. PMID: 32355199; PMCID: PMC7192906.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Antimalarial Resistance in the DRC</title>
      <link>https://nicholasbrazeau.com/project/veritydrc/</link>
      <pubDate>Thu, 30 Apr 2020 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/veritydrc/</guid>
      <description>&lt;p&gt;Using a massively parallel amplicon sequencing barcode approach, we used genomic analyses to demonstrate that the DRC appears to be a &amp;ldquo;mixing pot&amp;rdquo; for &lt;em&gt;P. falciparum&lt;/em&gt; infections across Sub-Saharan Africa. In addition, we identified strong signals of selection to antimalarial drugs in the DRC that likely have driven gene flow patterns across the country. Alongside analytic support, I lead the analyses on detecting selection using adapted extended haplotype heterozygosity approaches. In addition, I led the bioinformatic analysis identifying the variants for the aforementioned barcode used in the study. This barcode has been used extensively by our research group, as well as several domestic and international groups (initial publication: Verity/Aydemir/Brazeau et al. 2020, Nat Comms).&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Tanzania-Zanzibar Transmission</title>
      <link>https://nicholasbrazeau.com/project/tzzb_ibd/</link>
      <pubDate>Thu, 30 Apr 2020 08:00:20 -0700</pubDate>
      <guid>https://nicholasbrazeau.com/project/tzzb_ibd/</guid>
      <description>&lt;p&gt;Significant achievements have been made in Zanzibar in reducing the burden of malaria. However, the region has not been able to achieve malaria elimination. We find that despite existing excellent control efforts, there is ample evidence for gene flow and importation between Zanzibar and mainland Tanzania. This study highlights the challenges for elimination campaigns in addressing sink-source dynamics and the difficulties of blocking genetic corridors, which in theory should lead to a lack of diversity and ecological collapse of the malaria parasite in regions undergoing elimination.&lt;/p&gt;
&lt;p&gt;This project was published as Morgan &amp;amp; Brazeau &lt;em&gt;et al.&lt;/em&gt; 2020 in the Malaria Journal&lt;sup id=&#34;fnref:1&#34;&gt;&lt;a href=&#34;#fn:1&#34; class=&#34;footnote-ref&#34; role=&#34;doc-noteref&#34;&gt;1&lt;/a&gt;&lt;/sup&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes&#34; role=&#34;doc-endnotes&#34;&gt;
&lt;hr&gt;
&lt;ol&gt;
&lt;li id=&#34;fn:1&#34;&gt;
&lt;p&gt;Morgan AP, Brazeau NF, Ngasala B, Mhamilawa LE, Denton M, Msellem M, Morris U, Filer DL, Aydemir O, Bailey JA, Parr JB, Mårtensson A, Bjorkman A, Juliano JJ. Falciparum malaria from coastal Tanzania and Zanzibar remains highly connected despite effective control efforts on the archipelago. Malar J. 2020 Jan 28;19(1):47. doi: 10.1186/s12936-020-3137-8. PMID: 31992305; PMCID: PMC6988337.&amp;#160;&lt;a href=&#34;#fnref:1&#34; class=&#34;footnote-backref&#34; role=&#34;doc-backlink&#34;&gt;&amp;#x21a9;&amp;#xfe0e;&lt;/a&gt;&lt;/p&gt;
&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Simulating Deterministic SIR Models in a Closed and Open Population Playground</title>
      <link>https://nicholasbrazeau.com/2020/04/27/simulating-deterministic-sir-models-in-a-closed-and-open-population-playground/</link>
      <pubDate>Mon, 27 Apr 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2020/04/27/simulating-deterministic-sir-models-in-a-closed-and-open-population-playground/</guid>
      <description>&lt;p&gt;Below, you will find code for creating a shiny flex-dashboard for simple SIR open and closed population models.&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;  ---
  title: &amp;#34;Simulating SIR Models in a Closed and Open Population&amp;#34;
  date: &amp;#34;`r format(Sys.time(), &amp;#39;%B %d, %Y&amp;#39;)`&amp;#34;
  editor_options:
    chunk_output_type: console
  output: flexdashboard::flex_dashboard
  runtime: shiny
  ---


  {r setup, include=FALSE}
  knitr::opts_chunk$set(echo = F, warning = F, message = F, fig.align = &amp;#39;center&amp;#39;, results = &amp;#39;hide&amp;#39;, fig.keep = &amp;#39;all&amp;#39;)
  library(tidyverse)
  library(cowplot)
  # https://rmarkdown.rstudio.com/flexdashboard/layouts.html#multiple_pages




  {r}
  #..............................................................
  # Open Model
  #..............................................................
  # stochastic simulator for the unobserved state process --&amp;gt; how cases are generated
  open_sir_step &amp;lt;- function(S, I, R, N, Beta, mu_IR, mu_L, delta.t){
    SI_events &amp;lt;- rbinom(n = 1, size = S, prob = 1 - exp((-(mu_L+Beta*(I/N)))*delta.t))
    SI_deaths &amp;lt;- rbinom(n = 1, size = SI_events, prob = mu_L/(mu_L + Beta*(I/N)))
    infected &amp;lt;- SI_events - SI_deaths
    IR_events &amp;lt;- rbinom(n = 1, size = I, prob = 1 - exp(-(mu_L+mu_IR)*delta.t))
    IR_deaths &amp;lt;- rbinom(n = 1, size = IR_events, prob = mu_L/(mu_L + mu_IR))
    recovered &amp;lt;- IR_events - IR_deaths
    recovered_deaths &amp;lt;- rbinom(n = 1, size = R, prob = 1 - exp(-mu_L))

    S &amp;lt;- S - infected + IR_deaths + recovered_deaths
    I &amp;lt;- I + infected - recovered - IR_deaths
    R &amp;lt;- R + recovered - recovered_deaths
    N &amp;lt;- S + I + R
    return(c(&amp;#34;N&amp;#34; = N, &amp;#34;S&amp;#34; = S, &amp;#34;I&amp;#34; = I, &amp;#34;R&amp;#34; = R))
  }
  # recursively just step through time now
  open_sir_wrapper &amp;lt;-  function(N, I0, R0, Beta, mu_IR, mu_L, time, ...){
    # set up
    S0 &amp;lt;- N - I0  - R0
    time.steps &amp;lt;- (time - dplyr::lag(time))
    # init
    ret &amp;lt;- matrix(NA, nrow = length(time.steps) , ncol = 4)
    ret[1,] &amp;lt;- open_sir_step(S = S0,
                              I = I0, R = R0, N = N,
                              Beta = Beta,
                              mu_IR = mu_IR,
                              mu_L = mu_L,
                              delta.t = 0)

    for (t in 2:length(time.steps)) {
      ret[t,] &amp;lt;-  open_sir_step(S = ret[t-1, 2],
                                 I = ret[t-1, 3],
                                 R = ret[t-1, 4],
                                 N = ret[t-1, 1],
                                 Beta = Beta,
                                 mu_IR = mu_IR,
                                 mu_L = mu_L,
                                 delta.t = time.steps[t]
      )
    }
    # out
    ret &amp;lt;- cbind.data.frame(time, ret)
    colnames(ret) &amp;lt;- c(&amp;#34;time&amp;#34;, &amp;#34;N&amp;#34;, &amp;#34;S&amp;#34;, &amp;#34;I&amp;#34;, &amp;#34;R&amp;#34;)
    return(ret)

  }

  #..............................................................
  # Closed Model
  #..............................................................
  closed_sir_step &amp;lt;- function(S,I, R, N, Beta, mu_IR, delta.t){
    dN_SI &amp;lt;- rbinom(n = 1, size = S, prob = 1 - exp(-Beta*(I/N)*delta.t))
    dN_IR &amp;lt;- rbinom(n = 1, size = I, prob = 1 - exp(-mu_IR*delta.t))
    S &amp;lt;- S - dN_SI
    I &amp;lt;- I + dN_SI - dN_IR
    R &amp;lt;- R + dN_IR
    return(c(&amp;#34;S&amp;#34; = S, &amp;#34;I&amp;#34; = I, &amp;#34;R&amp;#34; = R))
  }

  # recursively just step through time now
  closed_sir_wrapper &amp;lt;-  function(N, I0, R0, Beta, mu_IR, time, ...){
    # set up
    S0 &amp;lt;- N - I0 - R0
    time.steps &amp;lt;- (time - dplyr::lag(time))
    # init
    ret &amp;lt;- matrix(NA, nrow = length(time.steps) , ncol = 3)
    ret[1,] &amp;lt;- closed_sir_step(S = S0,
                                I = I0, R = R0, N = N,
                                Beta = Beta,
                                mu_IR = mu_IR, delta.t = 0)

    for (t in 2:length(time.steps)) {
      ret[t,] &amp;lt;-  closed_sir_step(S = ret[t-1, 1],
                                   I = ret[t-1, 2],
                                   R = ret[t-1, 3],
                                   N = N, # closed population
                                   Beta = Beta,
                                   mu_IR = mu_IR,
                                   delta.t = time.steps[t]
      )
    }
    # out
    ret &amp;lt;- cbind.data.frame(time, ret)
    colnames(ret) &amp;lt;- c(&amp;#34;time&amp;#34;, &amp;#34;S&amp;#34;, &amp;#34;I&amp;#34;, &amp;#34;R&amp;#34;)
    return(ret)

  }




  ### Sidebar {.sidebar}
  {r, results=&amp;#39;asis&amp;#39;}
  #..............................................................
  # Sliding Panel for Different Parameters we are estimating
  #..............................................................

  inputPanel(
    sliderInput(&amp;#34;Time&amp;#34;, label = &amp;#34;Time Observed Since Start of Epidemic&amp;#34;,
                min = 0, max = 1e3, value = 500, step = 100),

    sliderInput(&amp;#34;mu_L&amp;#34;, label = &amp;#34;Birth &amp;amp; Death Rate&amp;#34;,
                min = 0.01, max = 0.1, value = 0.01, step = 0.005),

    sliderInput(&amp;#34;beta&amp;#34;, label = &amp;#34;Beta (Effective Contact Rate)&amp;#34;,
                min = 0, max = 1, value = 0.2, step = 0.001),

    sliderInput(&amp;#34;mu_IR&amp;#34;, label = &amp;#34;Gamma (Rate of Recovery)&amp;#34;,
                min = 0, max = 0.5, value = 0.1, step = 0.005),

    actionLink(&amp;#34;button&amp;#34;, &amp;#34;Ruh Roh!&amp;#34;, icon(&amp;#34;bug&amp;#34;),
               style=&amp;#34;color: #fff; background-color: #337ab7; border-color: #2e6da4&amp;#34;)

  )





  ### SIR Closed vs. Open

  {r, results=&amp;#39;asis&amp;#39;, fig.align=&amp;#39;center&amp;#39;, fig.height=11, fig.width=8}

  renderPlot({ withProgress(message = &amp;#39;Making plot&amp;#39;, {
    # re-render button
    input$button
    #..............................................................
    # plot closed
    #..............................................................
    closed_truth &amp;lt;- closed_sir_wrapper(N = 1e5,
                                        I0 = 1,
                                        R0 = 0,
                                        Beta = input$beta,
                                        mu_IR = input$mu_IR,
                                        time = 1:input$Time)

    closed_sir_plot &amp;lt;- closed_truth %&amp;gt;%
      tidyr::gather(., key = &amp;#34;compartment&amp;#34;, &amp;#34;count&amp;#34;, 2:ncol(.)) %&amp;gt;%
      dplyr::mutate(Compartment = factor(compartment, levels = c(&amp;#34;S&amp;#34;, &amp;#34;I&amp;#34;, &amp;#34;R&amp;#34;))) %&amp;gt;%
      ggplot() +
      geom_line(aes(x=time, y=count, color = Compartment), size = 2, alpha = 0.9) +
      scale_color_manual(&amp;#34;&amp;#34;, values = c(&amp;#34;#2171b5&amp;#34;, &amp;#34;#e41a1c&amp;#34;, &amp;#34;#6a51a3&amp;#34;)) +
      xlab(&amp;#34;Time&amp;#34;) + ylab(&amp;#34;N&amp;#34;) + ggtitle(&amp;#34;SIR Closed Population&amp;#34;) +
      scale_y_continuous(label = scales::unit_format(big.mark = &amp;#34;,&amp;#34;, scale = 1, unit = &amp;#34;&amp;#34;)) +
      theme_bw() +
      theme(
        plot.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5,  hjust = 0.5, size = 18),
        axis.text.x = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14),
        axis.text.y = element_text(family = &amp;#34;Helvetica&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14, angle = 45),
        legend.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5, size = 15),
        legend.text = element_text(family = &amp;#34;Helvetica&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14),
        panel.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        plot.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        legend.background = element_rect(fill = &amp;#34;transparent&amp;#34;))



    #..............................................................
    # plot OPEN MODEL
    #..............................................................
    open_truth &amp;lt;- open_sir_wrapper(N = 1e5,
                                    I0 = 1,
                                    R0 = 0,
                                    Beta = input$beta,
                                    mu_IR = input$mu_IR,
                                    mu_L = input$mu_L,
                                    time = 1:input$Time)



    open_truthPlot &amp;lt;- open_truth %&amp;gt;%
      dplyr::select(-c(&amp;#34;N&amp;#34;)) %&amp;gt;%
      tidyr::gather(., key = &amp;#34;compartment&amp;#34;, &amp;#34;count&amp;#34;, 2:ncol(.)) %&amp;gt;%
      dplyr::mutate(Compartment = factor(compartment, levels = c(&amp;#34;S&amp;#34;, &amp;#34;I&amp;#34;, &amp;#34;R&amp;#34;))) %&amp;gt;%
      ggplot() +
      geom_line(aes(x=time, y=count, color = Compartment), size = 2, alpha = 0.9) +
      scale_color_manual(&amp;#34;&amp;#34;, values = c(&amp;#34;#2171b5&amp;#34;, &amp;#34;#e41a1c&amp;#34;, &amp;#34;#6a51a3&amp;#34;)) +
      xlab(&amp;#34;Time&amp;#34;) + ylab(&amp;#34;N&amp;#34;) + ggtitle(&amp;#34;SIR Open Population&amp;#34;) +
      scale_y_continuous(label = scales::unit_format(big.mark = &amp;#34;,&amp;#34;, scale = 1, unit = &amp;#34;&amp;#34;)) +
      theme_bw() +
      theme(
        plot.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5,  hjust = 0.5, size = 18),
        axis.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5, size = 15),
        axis.text.x = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14),
        axis.text.y = element_text(family = &amp;#34;Helvetica&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14, angle = 45),
        legend.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5, size = 15),
        legend.text = element_text(family = &amp;#34;Helvetica&amp;#34;, hjust = 0.5, vjust = 0.5, size = 14),
        panel.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        plot.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        legend.background = element_rect(fill = &amp;#34;transparent&amp;#34;))

  }) # end of progress bar

    #..............................................................
    # plot out
    #..............................................................
    toprow &amp;lt;- cowplot::plot_grid(closed_sir_plot, open_truthPlot, nrow = 1)


    # R0
    R0 &amp;lt;- round(input$beta / (input$mu_IR + input$mu_L), 2)
    bottomrow &amp;lt;- ggplot() + geom_text(aes(0,0,
                                          label= paste0(&amp;#34;R[0] %~~% rho*c*D %~~% beta / (gamma + mu[L]) %~~%&amp;#34;, R0)), parse=TRUE, size = 10, fontface = &amp;#34;bold&amp;#34;) +
      theme_minimal() +
      theme(
        panel.grid = element_blank(),
        axis.text = element_blank(),
        axis.title = element_blank()
      ) + xlim(-0.1, 0.1) + ylim(-0.1, 0.1)


    cowplot::plot_grid(toprow, bottomrow, nrow = 2, rel_heights = c(4, 1))
  })
&lt;/code&gt;&lt;/pre&gt;</description>
    </item>
    
    <item>
      <title>Stochastic Simulations for Flattening the Curve Playground</title>
      <link>https://nicholasbrazeau.com/2020/04/27/stochastic-simulations-for-flattening-the-curve-playground/</link>
      <pubDate>Mon, 27 Apr 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/2020/04/27/stochastic-simulations-for-flattening-the-curve-playground/</guid>
      <description>&lt;p&gt;Below, you will find code for creating a shiny flex-dashboard for performing simple stochastic simulations with one time-interruption corresponding to an intervention (unrealistically simulated all at once). Code relies on the excellent EpiModel R package.&lt;/p&gt;
&lt;pre tabindex=&#34;0&#34;&gt;&lt;code&gt;   ---
  title: &amp;#34;Stochastic Simulations for Flattening the Curve&amp;#34;
  date: &amp;#34;`r format(Sys.time(), &amp;#39;%B %d, %Y&amp;#39;)`&amp;#34;
  editor_options:
    chunk_output_type: console
  output: flexdashboard::flex_dashboard
  runtime: shiny
  ---


  {r setup, include=FALSE}
  knitr::opts_chunk$set(echo = F, warning = F, message = F, fig.align = &amp;#39;center&amp;#39;, results = &amp;#39;hide&amp;#39;, fig.keep = &amp;#39;all&amp;#39;)
  library(tidyverse)
  library(EpiModel)
  library(furrr)
  # https://rmarkdown.rstudio.com/flexdashboard/layouts.html#multiple_pages



  ### Sidebar {.sidebar}

  {r, results=&amp;#39;asis&amp;#39;}
  #..............................................................
  # Sliding Panel for Different Parameters we are estimating
  #..............................................................

  inputPanel(
    sliderInput(&amp;#34;ntime&amp;#34;, label = &amp;#34;Time of Intervention&amp;#34;,
                min = 0, max = 200, value = 100, step = 10),

    sliderInput(&amp;#34;obstime&amp;#34;, label = &amp;#34;Epidemic Time-Span&amp;#34;,
                min = 0, max = 300, value = 200, step = 50),

    sliderInput(&amp;#34;inf.prob&amp;#34;, label = &amp;#34;Unmitigated Prob. of Infxn&amp;#34;,
                min = 0, max = 1, value = 0.5, step = 0.05),

    sliderInput(&amp;#34;act.rate&amp;#34;, label = &amp;#34;Unmitigated Prob. of Contact&amp;#34;,
                min = 0, max = 1, value = 0.5, step = 0.05),

    sliderInput(&amp;#34;newinf.prob&amp;#34;, label = &amp;#34;Mitigated Prob. of Infxn&amp;#34;,
                min = 0, max = 1, value = 0.25, step = 0.05),

    sliderInput(&amp;#34;newact.rate&amp;#34;, label = &amp;#34;Mitigated Prob. of Contact&amp;#34;,
                min = 0, max = 1, value = 0.25, step = 0.05),

    actionLink(&amp;#34;button&amp;#34;, &amp;#34;Ruh Roh!&amp;#34;, icon(&amp;#34;bug&amp;#34;),
               style=&amp;#34;color: #fff; background-color: #337ab7; border-color: #2e6da4&amp;#34;)

  )






 ### Stochastic Interventions

  {r, results=&amp;#39;asis&amp;#39;, fig.align=&amp;#39;center&amp;#39;, fig.height=11, fig.width=8}

  renderPlot({ withProgress(message = &amp;#39;Making plot&amp;#39;, {
    # re-render button
    input$button

    # make unmitigated model
    param &amp;lt;- param.icm(inf.prob = input$inf.prob, act.rate = input$act.rate, rec.rate = 0.01)
    init &amp;lt;- init.icm(s.num = 1e3, i.num = 1, r.num = 0)
    control &amp;lt;- control.icm(type = &amp;#34;SIR&amp;#34;, nsims = 20, nsteps = input$ntime)
    mod.unmit &amp;lt;- icm(param, init, control)

    # cheap way to have an intervention
    unmitdat &amp;lt;- as.data.frame(mod.unmit)
    new_init &amp;lt;- unmitdat %&amp;gt;%
      dplyr::filter(time == input$ntime) %&amp;gt;%
      dplyr::select(c(&amp;#34;s.num&amp;#34;, &amp;#34;i.num&amp;#34;, &amp;#34;r.num&amp;#34;)) %&amp;gt;%
      dplyr::mutate(endtime = input$obstime - input$ntime,
                    newinf.prob = input$newinf.prob,
                    newact.rate = input$newact.rate)

    wrap_icm &amp;lt;- function(newinf.prob, newact.rate, s.num, i.num, r.num, endtime){
      newparam &amp;lt;- param.icm(inf.prob = newinf.prob, act.rate = newact.rate, rec.rate = 0.01)
      newinit &amp;lt;- init.icm(s.num = as.numeric(s.num),
                          i.num = as.numeric(i.num),
                          r.num = as.numeric(r.num)) # as.numeric for stupid corner case
      newcontrol &amp;lt;- control.icm(type = &amp;#34;SIR&amp;#34;, nsims = 1, nsteps = as.numeric(endtime))
      # out
      mod &amp;lt;- icm(newparam, newinit, newcontrol)
      return(mod)
    }

    # mitigation
    mit.icm &amp;lt;- furrr::future_pmap(new_init, wrap_icm)
    mitdat &amp;lt;- lapply(mit.icm, function(x){ret &amp;lt;- as.data.frame(x); ret[, colnames(ret) != &amp;#34;sim&amp;#34;]} )
    mitdat &amp;lt;- mitdat %&amp;gt;%
      dplyr::bind_rows(., .id = &amp;#34;sim&amp;#34;)  %&amp;gt;%
      dplyr::mutate(time = input$ntime + time)


    fulldat &amp;lt;- rbind.data.frame(unmitdat, mitdat)
    df.mean &amp;lt;- fulldat %&amp;gt;%
      dplyr::group_by(time) %&amp;gt;%
      dplyr::summarise(
        s.num = mean(s.num),
        i.num = mean(i.num),
        r.num = mean(r.num),
      )
    # plot
    ggplot() +
      geom_line(data = fulldat, mapping = aes(time, s.num, group = sim), alpha = 0.25,
                lwd = 0.5, color = &amp;#34;#238b45&amp;#34;) +
      geom_line(data = df.mean, mapping = aes(time, s.num), color = &amp;#34;#238b45&amp;#34;, lwd = 1.2) +
      geom_line(data = fulldat, mapping = aes(time, i.num, group = sim), alpha = 0.25,
                lwd = 0.55, color = &amp;#34;#cb181d&amp;#34;) +
      geom_line(data = df.mean, mapping = aes(time, i.num), color = &amp;#34;#cb181d&amp;#34;, lwd = 1.2) +
      geom_line(data = fulldat, mapping = aes(time, r.num, group = sim), alpha = 0.25,
                lwd = 0.55, color = &amp;#34;#54278f&amp;#34;) +
      geom_line(data = df.mean, mapping = aes(time, r.num), color = &amp;#34;#54278f&amp;#34;, lwd = 1.2) +
      geom_vline(data = fulldat, aes(xintercept = input$ntime), color = &amp;#34;#000000&amp;#34;, linetype = &amp;#34;dashed&amp;#34;, size = 1.5, alpha = 0.8) +
      xlab(&amp;#34;Time&amp;#34;) + ylab(&amp;#34;Num.&amp;#34;) + ggtitle(&amp;#34;Stochastic SIR Model Runs with Intervention (Black)&amp;#34;) +
      theme_minimal() +
      theme(
        plot.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, vjust = 0.5,  hjust = 0.5, size = 22),
        axis.title = element_text(family = &amp;#34;Helvetica&amp;#34;, face = &amp;#34;bold&amp;#34;, hjust = 0.5, vjust = 0.5, size = 18),
        axis.text = element_text(family = &amp;#34;Helvetica&amp;#34;, hjust = 0.5, vjust = 0.5, size = 17),
        panel.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        plot.background = element_rect(fill = &amp;#34;transparent&amp;#34;),
        axis.line = element_line(color = &amp;#34;#000000&amp;#34;, size = 1.2),
        legend.position = &amp;#34;none&amp;#34;)

  }) # end of progress bar
  })
&lt;/code&gt;&lt;/pre&gt;</description>
    </item>
    
    <item>
      <title>The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC</title>
      <link>https://nicholasbrazeau.com/publication/verity-impact-2020/</link>
      <pubDate>Wed, 01 Apr 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/verity-impact-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Anonymised and aggregated crowd level mobility data from mobile phones suggests that initial compliance with COVID-19 social distancing interventions was high and geographically consistent across the UK</title>
      <link>https://nicholasbrazeau.com/publication/jeffrey-anonymised-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/jeffrey-anonymised-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Daptomycin exposure promotes irreversible loss of daptomycin susceptibility in clinical S. epidermidis infection co-incident with an isolated single point mutation in WalK</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-daptomycin-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-daptomycin-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Demography and population structure of falciparum malaria in Tanzania and Zanzibar underscores the role of importation in elimination</title>
      <link>https://nicholasbrazeau.com/publication/morgan-tanzania-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/morgan-tanzania-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Falciparum malaria from coastal Tanzania and Zanzibar remains highly connected despite effective control efforts on the archipelago</title>
      <link>https://nicholasbrazeau.com/publication/morgan-falciparum-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/morgan-falciparum-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Loss of daptomycin susceptibility in clinical Staphylococcus epidermidis infection coincided with variants in WalK</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-loss-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-loss-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Selection of Cytochrome B Mutants is Rare Among Plasmodium falciparum Patients Failing Treatment with Atovaquone-Proguanil in Cambodia</title>
      <link>https://nicholasbrazeau.com/publication/lin-cytochrome-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/lin-cytochrome-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Impact of Antimalarial Resistance on the Genetic Structure of Plasmodium falciparum in the DRC</title>
      <link>https://nicholasbrazeau.com/publication/verity-antimalarial-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/verity-antimalarial-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Under the Radar: Epidemiology of Plasmodium ovale infections in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/mitchell-ovale-2020/</link>
      <pubDate>Wed, 01 Jan 2020 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/mitchell-ovale-2020/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The Epidemiology of Asymptomatic P. vivax Among Adults in the Democratic Republic of the Congoo</title>
      <link>https://nicholasbrazeau.com/talk/discent-astmh/</link>
      <pubDate>Fri, 22 Nov 2019 08:00:00 -0800</pubDate>
      <guid>https://nicholasbrazeau.com/talk/discent-astmh/</guid>
      <description>


&lt;p&gt;Presentation of the first aim of my PhD dissertation, which focused on the epidemiology of &lt;em&gt;P. vivax&lt;/em&gt; in the Democratic Republic of the Congo, at the annual American Society of Tropical Medicine and Hygiene conference. This work is now published in Nature Communications&lt;a href=&#34;#fn1&#34; class=&#34;footnote-ref&#34; id=&#34;fnref1&#34;&gt;&lt;sup&gt;1&lt;/sup&gt;&lt;/a&gt;.&lt;/p&gt;
&lt;div class=&#34;footnotes footnotes-end-of-document&#34;&gt;
&lt;hr /&gt;
&lt;ol&gt;
&lt;li id=&#34;fn1&#34;&gt;&lt;p&gt;Brazeau NF, Mitchell CL, Morgan AP, Deutsch-Feldman M, Watson OJ, Thwai KL, Gelabert P, van Dorp L, Keeler CY, Waltmann A, Emch M, Gartner V, Redelings B, Wray GA, Mwandagalirwa MK, Tshefu AK, Likwela JL, Edwards JK, Verity R, Parr JB, Meshnick SR, Juliano JJ. The epidemiology of Plasmodium vivax among adults in the Democratic Republic of the Congo. Nat Commun. 2021 Jul 7;12(1):4169. doi: 10.1038/s41467-021-24216-3. PMID: 34234124; PMCID: PMC8263614.&lt;a href=&#34;#fnref1&#34; class=&#34;footnote-back&#34;&gt;↩︎&lt;/a&gt;&lt;/p&gt;&lt;/li&gt;
&lt;/ol&gt;
&lt;/div&gt;
</description>
    </item>
    
    <item>
      <title>Pooled Deep Sequencing of Drug Resistance Loci from Plasmodium falciparum Parasites across Ethiopia</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-pooled-2019/</link>
      <pubDate>Fri, 01 Nov 2019 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-pooled-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Prevalence of Molecular Markers of Antimalarial Drug Resistance across Altitudinal Transmission Zones in Highland Western Uganda</title>
      <link>https://nicholasbrazeau.com/publication/boyce-prevalence-2019/</link>
      <pubDate>Tue, 01 Oct 2019 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/boyce-prevalence-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo</title>
      <link>https://nicholasbrazeau.com/publication/deutsch-feldman-changing-2019/</link>
      <pubDate>Tue, 01 Oct 2019 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/deutsch-feldman-changing-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Plasmodium vivax chloroquine resistance links to pvcrt transcription in a genetic cross</title>
      <link>https://nicholasbrazeau.com/publication/sa-plasmodium-2019/</link>
      <pubDate>Sun, 01 Sep 2019 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/sa-plasmodium-2019/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Plasmodium vivax Infections in Duffy-Negative Individuals in the Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-plasmodium-2018/</link>
      <pubDate>Thu, 01 Nov 2018 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-plasmodium-2018/</guid>
      <description></description>
    </item>
    
    <item>
      <title>polyIBD: Inferring Identity by Descent in Complex, Polyclonal Infections</title>
      <link>https://nicholasbrazeau.com/talk/discent-astmh/</link>
      <pubDate>Tue, 12 Jun 2018 08:00:00 -0800</pubDate>
      <guid>https://nicholasbrazeau.com/talk/discent-astmh/</guid>
      <description>


&lt;p&gt;Presentation at the annual Genomic Epidemiology of Malaria conference presenting early work on &lt;code&gt;polyIBD&lt;/code&gt; a hidden Markov model for inferring identity by descent in polyclonal infections using a Bayesian framework. This project is currently in preparation.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Implementation and Evaluation of Shared Medical Appointments for Type 2 Diabetes at a Free, Student-Run Clinic in Alamance County, North Carolina</title>
      <link>https://nicholasbrazeau.com/publication/kahkoska-implementation-2018/</link>
      <pubDate>Mon, 01 Jan 2018 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/kahkoska-implementation-2018/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Whole Genome Analysis of Polyclonal Plasmodium vivax Relapses in Cambodia</title>
      <link>https://nicholasbrazeau.com/talk/pvrelapse-astmh/</link>
      <pubDate>Wed, 08 Nov 2017 08:00:00 -0800</pubDate>
      <guid>https://nicholasbrazeau.com/talk/pvrelapse-astmh/</guid>
      <description>


&lt;p&gt;Oral presentation at the annual American Society of Tropical Medicine and Hygiene conference analyzing the genomics of &lt;em&gt;P. vivax&lt;/em&gt; relapses from Cambodia.&lt;/p&gt;
</description>
    </item>
    
    <item>
      <title>Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia</title>
      <link>https://nicholasbrazeau.com/publication/parobek-partner-drug-2017/</link>
      <pubDate>Thu, 01 Jun 2017 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/parobek-partner-drug-2017/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Longitudinal Pooled Deep Sequencing of the Plasmodium vivax K12 Kelch Gene in Cambodia Reveals a Lack of Selection by Artemisinin</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-longitudinal-2016/</link>
      <pubDate>Thu, 01 Dec 2016 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-longitudinal-2016/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Distribution of a Chimpanzee Social Custom Is Explained by Matrilineal Relationship Rather Than Conformity</title>
      <link>https://nicholasbrazeau.com/publication/wrangham-distribution-2016/</link>
      <pubDate>Tue, 01 Nov 2016 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/wrangham-distribution-2016/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Exclusive Breastfeeding and Clinical Malaria Risk in 6-Month-Old Infants: A Cross-Sectional Study from Kinshasa, Democratic Republic of the Congo</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-exclusive-2016/</link>
      <pubDate>Sat, 01 Oct 2016 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-exclusive-2016/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Pooled Amplicon Deep Sequencing of Candidate Plasmodium falciparum Transmission-Blocking Vaccine Antigens</title>
      <link>https://nicholasbrazeau.com/publication/juliano-pooled-2016/</link>
      <pubDate>Fri, 01 Jan 2016 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/juliano-pooled-2016/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Dental eruption in East African wild chimpanzees</title>
      <link>https://nicholasbrazeau.com/publication/machanda-dental-2015/</link>
      <pubDate>Fri, 01 May 2015 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/machanda-dental-2015/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Critical limb ischemia: an update for interventional radiologists</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-critical-2013/</link>
      <pubDate>Mon, 01 Apr 2013 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-critical-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>May-Thurner syndrome: diagnosis and management</title>
      <link>https://nicholasbrazeau.com/publication/brazeau-may-thurner-2013/</link>
      <pubDate>Fri, 01 Mar 2013 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/brazeau-may-thurner-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>May-Thurner syndrome: can it be diagnosed by a single MR venography study?</title>
      <link>https://nicholasbrazeau.com/publication/mcdermott-may-thurner-2013/</link>
      <pubDate>Fri, 01 Feb 2013 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publication/mcdermott-may-thurner-2013/</guid>
      <description></description>
    </item>
    
    <item>
      <title>About Me</title>
      <link>https://nicholasbrazeau.com/about/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/about/</guid>
      <description></description>
    </item>
    
    <item>
      <title>About Me</title>
      <link>https://nicholasbrazeau.com/contact/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/contact/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Consulting</title>
      <link>https://nicholasbrazeau.com/consulting/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/consulting/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Products</title>
      <link>https://nicholasbrazeau.com/publications/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/publications/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Projects</title>
      <link>https://nicholasbrazeau.com/research/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/research/</guid>
      <description></description>
    </item>
    
    <item>
      <title>Service</title>
      <link>https://nicholasbrazeau.com/service/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/service/</guid>
      <description></description>
    </item>
    
    <item>
      <title>What Makes Pandemic Prediction Difficult?</title>
      <link>https://nicholasbrazeau.com/project/pipp/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      <guid>https://nicholasbrazeau.com/project/pipp/</guid>
      <description>&lt;p&gt;Briefly, the primary objective of this project was to identify methods that disrupt and/or enhance the predictability of infectious disease dynamics (IDD) of emerging outbreaks. We specifically focused on the variation in final sizes (total number of infected individuals) due to differences in contact networks, with plans to extend our framework as incidence over time versus focusing solely on the epidemic final siz]. Our focus on contact networks is based on the assumption that transmission parameters can be readily measured early in an epidemic. As a result, while contact patterns are difficult to measure, they are the pragmatic force driving uncertainty in the predictions of outbreak sizes. We also were interested in using a variation of a GAN approach to train a &amp;ldquo;prophet&amp;rdquo; CNN (connected to a fully connected FFNN) prediction model that &amp;ldquo;fought&amp;rdquo; with a VAE demon model.&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
